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ABSTRACT
Tendons and ligaments insert into bone through a transitional tissue termed the enthesis
which is susceptible to injury and difficult to repair. Entheses contain a region of
calcified fibrocartilage (CFC), however mineral-associated proteins in this tissue remain
poorly characterized. Bone sialoprotein (BSP) is a phosphoprotein associated with
mineralizing tissues. In these studies BSP was identified in the CFC of entheses by
immunohistochemistry. Analysis of the entheses of Bsp-/- mice indicate abnormalities in
the CFC. Compared to controls, the CFC of the quadriceps tendon enthesis is 28% and 41
% longer in 15 week and 14 month old Bsp-/- mice, respectively. MicroCT and Raman
spectroscopic analysis of the CFC in Bsp-/- mice demonstrate that mineral content is
similar between genotypes. Mechanical studies show that the Bsp-/- patellar tendon is
larger in cross-sectional area yet mechanically weaker. These data suggest BSP is
involved in the regulation and growth of the CFC.
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CHAPTER ONE

LITERATURE REVIEW

2
1.1

Mineralized Tissues
Biomineralization refers to the processes by which organisms form minerals

(Lowenstam and Weiner, 1989). It requires the selective extraction and uptake of
elements from the local environment and their incorporation into functional structures
under strict biological control. The earliest fossil evidence of biomineralization dates
back 3.5 billion years (Lepot et al., 2008) and has since been observed in all five of the
biological kingdoms (Lowenstam and Weiner, 1989). Mineralized tissues are biological
matrices that have incorporated inorganic minerals such as calcium and phosphorus into
their structure. Mineralized tissues serve a variety of functions. They can act as protective
armor, such as a shell, they can be involved in cutting and grinding functions, such as
teeth, and can offer support and stability, as in the skeleton. Perhaps the most
recognizable, and by far the best characterized, mineralized tissue is that of mammalian
bone, of which a brief description follows.
Bone is a complex connective tissue composed of three main phases: the cellular
phase, the inorganic phase, and the organic phase. The major cell types in bone are
osteoblasts, osteocytes and osteoclasts. Osteoblasts are anabolic cells associated with the
secretion of matrix and the deposition of mineral. Osteocytes, derived from osteoblasts
that have become entombed within the matrix of the bone, are associated with its
regulation and homeostasis. Osteoclasts are catabolic cells involved in the resorption and
remodeling of bone, releasing mineral and breaking down the extracellular matrix. The
mineral content of bone, constituting the inorganic phase, is largely hydroxyapatite (HA),
a stable crystal of calcium phosphate with unit formula Ca10(PO4)6(OH)2. HA deposition
is facilitated by osteoblasts into an organic matrix (the organic phase) primarily
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comprised of type I collagen. Roughly 10% of this matrix consists of non-collagenous
proteins which serve a variety of functions such as cell attachment and signaling,
regulation of mineral formation, which includes nucleation, binding and inhibition, as
well as structural functions.
Bones form through two major processes: intramembranous ossification and
endochondral ossification. Flat bones, such as the components of the skull and scapula
form through intramembranous ossification in which mesenchymal tissues become
mineralized without a cartilage intermediate. Long bones, such as the femur and
humerus, form through the process of endochondral ossification. Endochondral
ossification begins embryonically when cells of the mesenchyme condense in regions that
will eventually become the long bones of the skeleton. These cells differentiate into
chondrocytes and form a cartilaginous anlage rich in type II collagen. Cells in the central
region of this structure begin to exit the cell cycle and enter hypertrophy, in which they
swell in size and excrete extracellular matrix. Hypertrophic chondrocytes secrete
angiogenic factors which promotes the invasion of blood vessels into the tissue. These
blood vessels deliver precursor cells which differentiate into osteoblasts and osteoclasts,
as well as blood and bone marrow-forming hematopoietic cells, to the developing bone.
This creates a primary ossification center in the middle of the anlage from which the
mineralization process begins. Osteoblasts promote mineral deposition, while osteoclasts
remodel the mineralized cartilage, facilitating the formation of lamellar bone. At the
terminals of the developing long bones, the epiphysis, secondary ossification centers also
form, creating a sandwich of resting, proliferative and hypertrophic chondrocytes termed
the epiphyseal growth plate. Proliferation, hypertrophy and mineralization of the
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chondrocytes of the growth plate drive the elongation and growth of the bone, until the
plates fuse at the end of puberty

1.2

Biomineralization
The exact mechanism by which HA is deposited into the type I collagen matrix of

bone is not fully understood. Serum concentrations of Ca2+ and PO43- are above the
solubility product constant of HA (Eidelman et al., 1987), however, they are kept from
precipitating in the body by a variety of inhibitors of crystal formation. In bone, type I
collagen fibrils are arranged in staggered arrays creating a periodic gap, call the hole
zone, every 67 nm (Katz and Li, 1973). It is within these hole zones that the initiation of
HA crystal formation takes place (Traub et al., 1992). It has been suggested that the
aqueous compartment created by the collagen hole zone is sufficiently small to exclude
large HA inhibitors, which leads to mineral deposition by the exclusion of inhibitors
(Nudelman et al., 2010; Price et al., 2009). Despite this evidence, type I collagen fibrils
themselves are not sufficient to nucleate HA formation (Blumenthal et al., 1990; Hunter
et al., 1986), indicating that some additional factor must be present to initiate HA crystal
formation. Acidic collagen binding proteins have long been speculated to fulfill this role
(Glimcher and Muir, 1984), of which members of the SIBLING protein family are the
prime examples.

1.3

SIBLINGs
Members of the Small Integrin Binding LIgand, N-linked Glycoprotein

(SIBLING) family are small phosphoproteins, often associated with mineralized tissues.
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The SIBLINGs have flexible structures and extensive post-translational modifications.
All members of the SIBLING family contain an RGD integrin-binding motif (Fisher et
al., 2001; George and Veis, 2008). The SIBLING genes are grouped in a 375 kbp cluster
on human chromosome 4 (Fisher and Fedarko, 2003) and mouse chromosome 5 (Crosby
et al., 1996). The family is comprised of 5 members: Osteopontin (OPN), Bone
Sialoprotein (BSP), Dentin Matrix Protein 1 (DMP1), Matrix Extracellular
Phosphoglycoprotein (MEPE) and Dentin Sialophosphoprotein (DSPP) (Fisher and
Fedarko, 2003; Fisher et al., 2001). Although the SIBLING proteins do not share a high
degree of sequence similarity, an examination of their exon structure reveals that the 5
genes are indeed related, likely resulting from gene duplication events and subsequent
divergences, facilitated by their flexible structure (Fisher and Fedarko, 2003).
All members of the SIBLING family seem to be involved with the regulation and
control of biological mineral deposition, although in different ways. The SIBLING
proteins are largely acidic, with isoelectric points ranging from 3.4-4.3, however MEPE
differs from the rest of the group as it is highly basic with a pI of 9.2 (Fisher and Fedarko,
2003) BSP, DMP1, DSPP are promoters of mineral deposition and are mostly found
within mineralized tissues, with greater concentrations of BSP found in bone, while
dentin contains greater amounts of DMP1 and DSPP (George and Veis, 2008). OPN and
MEPE are potent inhibitors of HA formation and are expressed ubiquitously, likely to
prevent ectopic calcification of soft tissues (George and Veis, 2008). Single knock-out
animals for each of the SIBLINGS have been created, with each displaying alterations in
the properties of their mineralized tissues, however the loss of a single SIBLING gene
does not result in an inability to form mineralized tissue (George and Veis, 2008). This
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suggests that the SIBLINGs work in concert with each other to control the process of
biomineralization in vivo and a great deal of functional redundancy is present within the
family. As the focus of this thesis is bone sialoprotein, an in depth discussion of BSP
follows.

1.4

Bone Sialoprotein
BSP is an intrinsically disordered and extensively post-translationally modified

phosphoprotein found in the mineralized tissues of bones and teeth. BSP was initially
isolated from bone in 1963 as a 23-kDa sialic acid-containing glycoprotein (Herring and
Kent, 1963)(Figure 1.1). By utilizing a dissociative extraction procedure, Fisher et al.
isolated a 70-80 kDa variant from calf bone, representing full length native BSP complete
with its post translational modifications (Fisher et al., 1983). The rat Bsp gene was first
sequenced in 1988 by Oldberg et al. (Oldberg et al., 1988). The amino acid sequences of
BSP have since been deduced in a variety of mammalian species and show a high level of
conservation, with specific domains showing identity approaching 90% (Goldberg and
Hunter, 2012).

1.4.1 Structure
Mammalian BSP contains an average of 300 amino acids, 20% of which are Glu
and 11% are Gly. Additionally a 16-residue signal sequence is present at the N-terminus.
Unmodified BSP has a pI of 3.9. BSP’s calculated mass based on amino acid composition
derived from the cDNA sequence is 33,549 Da; however, two independent MALDI-TOF
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Figure 1.1 Schematic of bone sialoprotein. BSP is approximately 300 amino acids long.
The collagen-binding sequence (yellow) spans residues 18-45. There are two polyglutamic acid sequences (red) responsible for HA nucleation. Finally, there is an integrinbinding RGD sequence (blue) at the C-terminus.
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mass spectroscopy studies of BSP found mean masses of 52.5 and 49.0 kDa (Wuttke et
al., 2001; Zaia et al., 2001). Broad mass peaks were observed in both these studies,
reflecting the significant heterogeneity of post-translation modifications on individual
BSP molecules. Oligosaccharides comprise approximately 30% of BSP’s weight and
BSP contains 23 sialic acid residues (Zaia et al., 2001). BSP (bovine) also contains 11
identified phosphorylation sites, however not all of these sites appear to be
phosphorylated on each molecule. MALDI-TOF mass spectroscopy studies on proteolytic
digests of BSP indicate that on average BSP molecules contain 5.8 phosphorylated serine
residues (Salih and Flückiger, 2004; Salih et al., 2002). BSP also contains several
sulfated tyrosine residues located in the C-terminal region of the protein. Structural
analyses of BSP utilizing circular dichroism spectropolarimetry, NMR and small-angle
X-ray scattering indicate the loose, flexible structure of an intrinsically disordered protein
(Fisher et al., 2001; Tye et al., 2003; Wuttke et al., 2001).

1.4.2 Collagen Binding
BSP binds to type I collagen fibrils with a high affinity (KD =12.1 nM) (Tye et al.,
2005). The highly conserved collagen-binding domain of BSP encompasses residues 1845 and is rich in hydrophobic and basic amino acids. The KD of BSP18-45 (150 nM) is
weaker than that of native, full-length BSP however, indicating that other regions of the
molecule are involved in stabilizing the interaction with collagen (Baht et al., 2008).
Intermolecular forces involved in this binding appear to be comprised mostly of
hydrophobic interactions, as elution of BSP with 1.0 M NaCl yielded little protein;
however, elution with acetonitrile, which disrupts hydrophobic interactions, resulted in
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the full release of BSP from a type I collagen affinity column (Baht et al., 2008). The
exact location that BSP binds to on the collagen molecule remains unknown, however
BSP appears to localize to the hole regions of type I collagen fibrils (Fujisawa et al.,
1995), which as previously mentioned are associated with early mineral formation
(Fratzl et al., 1991; Traub et al., 1992).

1.4.3 Hydroxyapatite Binding and Nucleation
BSP’s many negatively charged groups confer HA binding properties. At
physiological salt concentrations, native rat BSP bind ~60 Ca2+ ions per molecule with
low affinity (Chen et al., 1992), however bone-derived porcine BSP’s affinity for HA is
higher with a KD of ~0.9 μM (Goldberg et al., 2001). This affinity is largely attributed to
the 2-3 contiguous Glu sequences present in the central region of the protein, as
competitive binding studies using synthetic poly-Asp and poly-Glu peptides reduced
BSP’s affinity for HA by 90% and 68% respectively (Goldberg et al., 2001).
Additionally, mutation of these poly-Glu sequences to poly-Ala sequences reduced in
vivo HA adsorption 4-fold (Wazen et al., 2007).
BSP is also a potent nucleator of HA formation as demonstrated by Hunter and
Goldberg using a steady-state agarose gel system (Hunter and Goldberg, 1993). This
group went on to show that BSP’s poly-Glu sequences are largely responsible for HA
formation (Goldberg et al., 1996). Synthetic peptides spanning BSP poly-Glu sequences
can mediate HA formation on its own, and a 2.5 fold increase in nucleation activity is
observed when these peptides are phosphorylated (Baht et al., 2010). Correspondingly,
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unmodified full length BSP also nucleates hydroxyapatite formation, however native BSP
with its post translational modifications is ~100 fold more potent (Goldberg et al., 1996).

1.4.4 Cell Attachment and Signaling
Akin to its other SIBLING members, BSP contains an RGD integrin-binding
motif, which is located towards its C-terminus. BSP’s RGD sequence is recognized by
the αvβ3 integrin (Oldberg et al., 1988), a receptor identified on the surfaces of osteoblasts
(Prince et al., 1991) and osteoclasts (Miyauchi et al., 1991; Ross et al., 1993) BSPmediated attachment of these cell types has been demonstrated respectively by
Somerman et al. and Helfrich et al. (Helfrich et al., 1992; Somerman et al., 1988). Cell
attachment of osteoblasts, fibroblasts, and chondrocytes is abolished by alteration to a
KAE sequence (Gill et al., 2008; Gordon et al., 2007; Harris et al., 2000). Eukaryotic cell
binding via an RGD-independent mechanism has also been described (Mintz et al.,
1993).
BSP has been shown to promote osteoblast differentiation and mineral formation
in cell culture (Cooper et al., 1998; Zhou et al., 1995). Furthermore, a reduction in
mineralized nodules was observed when osteoblast-like cell cultures were treated with an
anti-BSP antibody (Boskey et al., 2008). Overexpression of BSP in primary rat calvarial
cells increased mineral formation and markers of osteoblast differentiation (Gordon et al.,
2007). Treatment with BSP and osteogenic media of human bone marrow-derived cells
resulted in a decrease in cell proliferation and promoted differentiation into osteoblasts
(Xia et al., 2011).
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BSP mediates Ca2+ signaling in osteoclasts through the αvβ3 integrin receptor
(Paniccia et al., 1995, 1993) and can modulate their activity. BSP is involved in the
generation of osteoclasts (Valverde et al., 2005, 2008) and stimulates in vitro bone
resorption (Raynal et al., 1996), however it is not critical for this process (Malaval et al.,
2008).

1.4.5 Tissue Distribution and Expression
BSP expression is largely restricted to mineralized tissue. BSP has long been
known to be expressed in osteoid tissue (Ganss et al., 1999) and has particularly strong
expression in developing bone (Bianco et al., 1991). BSP is relatively uniform in its
distribution throughout the bone, where it is likely bound to and entrapped by HA
(Bianco et al., 1993; Chen et al., 1993; Kasugai et al., 1992; Riminucci et al., 1995)
although BSP protein is particularly concentrated at the mineralization front (Bianco et
al., 1993; Riminucci et al., 1995; Shapiro et al., 1993). Chen et al. showed BSP mRNA in
rat tissue is abundant during times of de novo bone synthesis and mineralization in bone,
dentin and cementum using northern blotting and in situ hybridization, however
expression declines as the animals matured, with little mRNA detected in 100 day old
rats (Chen et al., 1992). Thus, BSP’s expression and localization coincides with the
formation of a mineralized matrix. BSP mRNA is abundant and easily detected in mature
osteoblasts and osteocytes, however it is not present in pre-osteoblastic cells, indicating
that BSP expression is induced upon differentiation (Bianco et al., 1991; Chen et al.,
1991). In line with its proposed role in de novo bone synthesis, BSP is also expressed by
the hypertrophic chondrocytes within the epiphyseal growth plate (Bianco et al., 1991).
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BSP expression has been detected in osteoclasts (Arai et al., 1995; Bianco et al., 1991),
suggesting that it is involved in the modulation of mineral resorption.
BSP is expressed in a variety of dental tissues, and may have a role in the
formation and maintenance of teeth. BSP protein and mRNA have been detected in both
dentin and cementum where it is expressed by odontoblasts and cementoblasts,
respectively (Chen et al., 1993; Somerman et al., 1991). Cementum in particular is rich in
BSP and BSP appears to be critical to the formation of acellular cementum (Foster et al.,
2013). Low levels of BSP have been detected in enamel and ameloblasts (Chen et al.,
1998). BSP has also been detected in three non-mineralized tissues; the trophoblastic
cells of the human placenta (Bianco et al., 1991), salivary glands (Ogbureke and Fisher,
2004) as well as platelets where it is probably endocytosed from the serum (Chenu and
Delmas, 1992).

1.4.6 In Vivo Function
Due to its tissue distribution, expressional patterns and biochemical properties,
BSP is thought to be involved in de novo bone synthesis. Specifically, BSP is believed to
bind to collagen fibers and nucleate HA formation, while also recruiting osteogenic cells
to sites of mineral formation (Ganss et al., 1999). A variety of in vivo studies support this
hypothesis. When BSP and type I collagen are implanted into calvarial defects of rats,
cell proliferation, osteoblast differentiation and mineral deposition are observed (Wang et
al., 2006; Xu et al., 2007). BSP implantation into the pulp of rat molars may also
stimulate dentinogenesis (Decup et al., 2000).
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Mice lacking the Bsp gene (Bsp-/-) demonstrate reduced body size and weight with
undermineralized fetal bones compared to wild-type littermates. At 4 months of age Bsp-/mice display thinner cortical bones than wild type mice and have increased trabecular
bone volume, however at 12 months few difference are apparent (Malaval et al., 2008).
This suggests that the defects are transient, and mutant mice eventually "catch up" with
their wild-type counterparts. Interestingly, mice which overexpress BSP via a CMV
promoter also display thinner cortical bone and mild dwarfism, although trabecular bone
volume is decreased in these animals (Valverde et al., 2008). Bone formation rate is
decreased in Bsp-/- mice, as is bone resorption and osteoclastogenesis (Boudiffa et al.,
2010; Malaval et al., 2008). Conversely, BSP overexpressing mice display increased
osteoclast activity and bone resorption (Valverde et al., 2008). Osteoblasts isolated from
Bsp-/- mice form fewer mineralizing colonies and express decreased levels of osteoblastic
cell markers (Malaval et al., 2008); however BSP overexpressing mice also display
decreased osteoblast populations and differentiation markers (Valverde et al., 2008).
Repair of cortical defects drilled into the femur of Bsp-/- mice is slowed compared
to wild type animals (Malaval et al., 2009), and marrow ablation models indicate primary
bone formation is also delayed (Wade-Gueye et al., 2012). Embryonic mice at 15.5 days
gestation display a delay in primary ossification (Holm et al., 2015). In newborn Bsp-/mice, microCT analysis of the skull revealed wider cranial sutures (Bouleftour et al.,
2014), suggesting a delay in membranous ossification.
Recent studies suggest that there are alterations in the growth plates of these
animals as well. Bouleftour et al. reported a thinner hypertrophic zone in the epiphyseal
plate of 6 day old Bsp-/- mice and a thinner proliferative zone and thicker hypertrophic
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zone at 3 weeks of age (Bouleftour et al., 2014). Holm et al. also report growth plate
abnormalities in the Bsp-/- mouse however this group observed an increase in the size of
the resting zone with a reciprocal decrease in the size of the proliferative zone in newborn
animals (Holm et al., 2015).
A significant periodontal phenotype has recently been uncovered in the Bsp -/mouse. The alveolar bone, into which the teeth are set, displays significant resorption in
Bsp-/- mice (Foster et al., 2013). Briefly mentioned previously, acellular cementum is a
thin mineralized tissue found along the apical portion of the root of the tooth, into which
the periodontal ligament (PDL) inserts and anchors the tooth into alveolar bone.
Immunohistochemical staining has demonstrated that acellular cementum is rich in BSP,
and this tissue is significantly reduced in Bsp-/- mice (Foster et al., 2013). Additionally,
the PDL in Bsp-/- mice is disorganized, with poorly aligned collagen fibers that do not
properly insert into the tooth root (Foster et al., 2013). This phenotype spurred us to
investigate other junctions between hard and soft tissues.

1.5

The Enthesis
Tendons and ligaments attach to bones through a transitional structure known as

the enthesis, however authors have given the structure several other names such as
osteotendious junction or simply the tendon-bone insertion (Benjamin and McGonagle,
2001; Benjamin et al., 2002). Entheses are vital to locomotion and movement as they
transmit the contractile force of skeletal muscles to their corresponding structures of the
skeleton proper. Due to the immense loads these structures bear, as well as the large
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differences in the mechanical properties of the two tissues they connect, entheses possess
unique mechanics and biology.
Entheses fall under two district categories which again have been called a variety
of different names including periosteal-diaphyseal and chondroapophyseal attachments as
well as indirect and direct attachments. For the purposes of this thesis we shall use the
terms fibrous enthesis and fibrocartilaginous enthesis, respectively, for these structures
since these are the consensus terms in the literature (Benjamin and McGonagle, 2001).

1.5.1 Fibrous Entheses
Fibrous insertions originating from tendon/ligaments usually occur over large
areas where they connect either directly with the osteoid tissue of the bone or indirectly
through the periosteum via perforating mineralized collagen fibers. When they attach to
long bones, fibrous entheses usually occur at the diaphysis (Benjamin et al., 2002). Two
examples of fibrous entheses are the tibial attachment of the medial collateral ligament of
the knee and the deltoid attachment to the humerus in the shoulder. Fibrous entheses have
received little research attention when compared to the fibrocartilaginous enthesis, which
is likely due to the latter’s clinical relevance. Indeed, the focus of this thesis too, is the
fibrocartilaginous enthesis.

1.5.2 Fibrocartilaginous Entheses
The far more common fibrocartilaginous enthesis is distinguished from the
fibrous enthesis by the presence of fibrocartilage in the transition from tendon/ligament to
bone and is of key clinical relevance as these are the structures most commonly damaged
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in tears of the rotator cuff and ligaments of the knee. Examples of fibrocartilaginous
entheses include the humeral attachment of the supraspinatus tendon (SST) and the
insertion of the quadriceps femoris tendon (QCT) into the back of the patella (Figure 1.2).
The fibrocartilaginous enthesis has traditionally been described as having four
transitional zones: dense fibrous connective tissue of the tendon, uncalcified
fibrocartilage, calcified fibrocartilage, and bone (Benjamin and McGonagle,
2001)(Figure 1.3).
The first zone of the fibrocartilaginous entheses is pure dense connective tissue of
the tendon/ligament. This zone is primarily composed of linear type I collagen fibers with
additional type III collagen, as well as small amounts of elastin and the proteoglycans
biglycan and decorin. The major cells of this tissue are the elongated spindle-shaped
fibroblasts which are responsible for the creation and maintenance of the tissue
(Benjamin and Ralphs, 2000).
Next follows a region of fibrocartilage, part of which is mineralized and part of
which is not, the calcified fibrocartilage (CFC) and uncalcified fibrocartilage (UFC).
Tendon gradually gives way to the UFC, which is composed mainly of type II collagen,
although type I and III collagen are also present. Proteoglycans that have been identified
in the UFC include decorin, biglycan, lumican, versican, and aggrecan and the cells that
populate this region referred to as fibrochondrocytes (Fukuta et al., 1998; Kumagai et al.,
1994; Waggett et al., 1998). Fibrochondrocytes are isolated from one another and do not
communicate with each other via gap junctions as the cells of the tendon and bone do,
thus creating a barrier to communication between tenocytes and osteocytes
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Figure 1.2 Anatomical location of selected fibrocartilaginous entheses. (A) Anterior
view of the bones, muscles, tendons and ligaments of the knee. Insertion of the
quadriceps femoris tendon into the back of the patella indicate (red arrow). (B) Posterior
view of the muscles and bones of the shoulder. Insertion of the supraspinatus tendon into
the humeral head indicated (red arrow).
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This figure was adapted from Gray’s Anatomy for Students, Third Edition, Drake RL, Vogl AW, Mitchell
AWM, Copyright Churchill Livingstone Elsevier (2015). Reproduced with permission from the publisher.
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Figure 1.3 The transitional zones of the fibrocartilaginous enthesis.
Fibrocartilaginous entheses have been classically divided into four zones: tendon,
uncalcified fibrocartilage (UFC), calcified fibrocartilage (CFC), and bone. The tendon
proper, made mostly of type I collagen, a region of fibrocartilage composed of type II
collagen that is divided into an uncalcified and calcified region. The boundary is called
the tidemark and indicates the edge of the mineralized tissue. The calcified fibrocartilage
gives way to bone. Bar = 100 µm
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(Ralphs et al., 1998). The UFC is more pliable than either the tendon or the CFC and it is
thought that its primary function is stress dissipation and force dampening. This is
evidenced by larger regions of UFC in entheses which vary more in their insertion angles
during joint movement (Benjamin and McGonagle, 2001; Benjamin and Ralphs, 1998).
A sharp boundary exists between the UFC and the CFC, termed the tidemark, and
represents the maximum extent of the mineralized zone of the fibrocartilaginous enthesis.
Using Raman spectroprobe analysis Schwartz et al. characterized the mineral gradient
that occurs between the UFC and CFC at the tidemark in the mouse supraspinatus tendon
insertion (Schwartz et al., 2012). Mineral increases from zero to maximal levels over a
length of approximately 20 µm, a relatively narrow band as the total length of the
calcified fibrocartilage of the murine supraspinatus tendon enthesis is roughly 100 µm.
Furthermore, although the length of the CFC increases as the animal ages, the length of
the mineral gradient remains the same. A separate study on the rat supraspinatus tendon
enthesis found a gradient with length of roughly 100 µm (Wopenka et al., 2008), however
it is not clear how the span of the gradient scales with the size of the animal.
The mineral content of the CFC beyond the gradient zone is constant across its
length (Schwartz et al., 2012), and the CFC has a slightly different matrix composition
than the UFC. Type II collagen is much more abundant here, although type I collagen can
still be detected. Furthermore, type X collagen is present in small amounts and its
expression is not transient, as it is in the growth plate (Fujioka et al., 1997).
The major proteoglycan of the CFC is aggrecan, and notably this is the only
region of the fibrocartilaginous enthesis where decorin is absent (Waggett et al., 1998).
Interestingly no mineral associated proteins have yet been described in the CFC, although
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Liu et al. observed asporin mRNA in the developing insertion of the patellar ligament to
the tibia (Liu et al., 2013). Asporin is a member of the leucine rich repeat family of
proteins, which includes the proteoglycans decorin and biglycan with collagen binding
and HA binding properties (Kalamajski et al., 2009; Lorenzo et al., 2001). The CFC is
intermediate in stiffness between tendon and bone and this characteristic is also thought
to assist in stress dissipation during movement and loading (Benjamin et al., 2002;
Fujioka et al., 1997).
The final zone of the fibrocartilaginous enthesis is bone, which has been
described previously. The junction between the CFC and the lamellae of the bone is
highly irregular, in contrast to the smooth straight line of the tidemark. This
interdigitating of bone and CFC is thought to create a firm joining of these tissues,
ultimately anchoring the tendon/ligament to the bone.

1.5.3 Development
The developmental pathways of the fibrocartilaginous enthesis are still being
explored. The structure can first be identified in mice at embryonic day 13.5 while an
apparently mature enthesis can be observed histologically as early as 21 days post-natal
(Zelzer et al., 2014). As discussed previously, the fibrocartilaginous enthesis is a
transitional tissue between bone and tendon, and as such, the origin of the enthesis is
likely to include developmental components from the two tissues it eventually unites.
Mentioned above, bone initially develops as a cartilaginous anlage composed of a
condensation of mesenchymal cells that differentiate into chondrocytes. A key regulator
of chondrocyte differentiation is the transcription factor Sox9 that is continually
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expressed by all chondroprogenitors and chondrocytes during chondrogenesis (Akiyama
et al., 2002; Dy et al., 2012; Ng et al., 1997; Zhao et al., 1997). Tenocyte differentiation
is largely controlled by a basic helix loop helix transcription factor known as scleraxis
(Scx) (Cserjesi et al., 1995; Murchison et al., 2007; Schweitzer et al., 2001).
Generally tendons and ligaments insert into bone at boney eminences or
protrusions, thus initial studies of the development of fibrocartilaginous entheses began
with these structures. Intriguingly, cell lineage tracing indicates that bone eminences are
not derived from the cartilaginous anlage of the bone but rather arise as a distinct unit
derived from a pool of progenitors which are appended onto the developing bone (Blitz et
al., 2013). Gene expression analysis of these progenitors reveals that they are positive for
both Sox9 and Scx (Blitz et al., 2013; Sugimoto et al., 2013). This observation has led
Zelzer et al. to propose the segregation model of enthesis development and cell
differentiation (Zelzer et al., 2014). In this model, the bone eminence, Sox9 Scx double
positive, progenitor cells differentiate and segregate into either the Sox9 positive cells of
the enthesis fibrocartilage, or the Scx positive cells of the incoming tendon, uniting the
two tissues without the need for a complex homing mechanism to direct a tendon to its
proper attachment point.
Other molecules have been identified to participate in the development of
entheses. Transforming growth factor β (TGFβ) is necessary for tenocyte differentiation
as evidenced by a lack of all tendinous tissue in mice which lack either the genes for
Tgfβ1 and Tgfβ2, or its receptor TgfβrII (Pryce et al., 2009). The role of TGFβ in bone is
poorly understood, as overexpression triggers chondrogenesis (Carrington et al., 1991;
Chimal-Monroy and Díaz de León, 1997; Kulyk et al., 1989; Leonard et al., 1991;
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Merino et al., 1998; Verrecchia and Mauviel, 2002) while lack of expression results in
mild phenotypes (Seo and Serra, 2007; Spagnoli et al., 2007; Verrecchia and Mauviel,
2002). At the developing enthesis, deletion of TgfβrII results in mice which lack bone
eminence progenitor cells (Blitz et al., 2013), indicating that the TGFβ signaling pathway
is required to commit mesenchymal cells to the enthesis development pathway. In
contrast, the Scx/bone morphogenic protein 4 (BMP4) pathway does not seem to be
involved in the specification of cells to enthesis development, as mice that lack these
genes still possess Sox9 positive bone eminence progenitors. However, this pathway is
involved in their differentiation as the bone eminence progenitors in both Scx-/- and Bmp4/-

mice fail to differentiate and do not express type II collagen (Blitz et al., 2013). Other

BMPs may be involved in enthesis development as well, as loss of the receptor for BMP2
and BMP7 results in the failure of bone eminences of the humerus to form (Ovchinnikov
et al., 2006). Dominant negative mutations in Bmp5 also cause alterations in bone
eminence formation (Ho et al., 2008).
The mechanism by which the developing enthesis mineralizes is largely unknown
however the process is speculated to be similar to endochondral ossification of the long
bones. Endochondral ossification is regulated in part by the Indian hedgehog (IHH)
pathway, which also seems to play a role in enthesis development. IHH is expressed by
hypertrophic chondrocytes as they terminally differentiate. IHH stimulates further
chondrocyte proliferation by binding to the membrane receptor Patched (Ptch) which
activates the membrane receptor Smoothened (Smo), resulting in the expression of
parathyroid hormone-related protein (PTHrP). PTHrP inhibits chondrocyte maturation
and mineralization and exercises negative feedback control on IHH, resulting in a loop in
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which chondrocyte proliferation and hypertrophy can be finely controlled, based on the
distance between the hypertrophic and proliferating chondrocytes. Expression of PTHrP
and IHH has been detected in the developing enthesis, suggesting a developmental role
for this pathway (Chen et al., 2006; Liu et al., 2012). Deletion of PTHrP in Scx
expressing cells appears to deleteriously effect the ability of osteoclasts to excavate
insertions for fibrous entheses (Wang et al., 2013). Constitutive expression of IHH in
Scx-expressing cells leads to enthesis marker expression in the central region of the
tendon (tendon midsubstance), such as type II collagen, where it is not normally
expressed (Liu et al., 2013). Deletion of Smo in Scx-expressing cells results in
chondrocyte impairment such that they fail to form fibrocartilage at the insertion.
Furthermore, adult animals lacking Smo in these cells lack a tidemark, indicating
mineralization is impaired (Liu et al., 2013). Although several studies have investigated
the role of classical endochondral ossification signaling pathways in enthesis
development, to date, protein regulators of mineralization remain wholly uncharacterized
in the development and function fibrocartilaginous enthesis.
Mechanical load has a significant influence on enthesis development. The role of
physical cues in the development of the musculoskeletal system has been extensively
studied (Galloway et al., 2013; Gkiatas and Lykissas, 2015). In the absence of muscle
forces, defects in bone size, shape and mineralization can occur (Gomez et al., 2007;
Mikic et al., 2000; Osborne et al., 2002; Sharir et al., 2011). Bone eminences too require
mechanical force to fully mature as evidenced by transplantation experiments
(Hamburger and Waugh, 1940; Hamburger, 1939, 1938). However, force is not required
for the initiation of eminence formation as mice with induced muscle paralysis possess
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stunted versions of these structures. It appears that instead, mechanical force drives
growth and cell proliferation (Blitz et al., 2009; Kahn et al., 2009), and as a result,
maturation of these structures in the absence of muscle force is delayed, with little or no
fibrocartilage present at 8 weeks of age (Das et al., 2011; Schwartz et al., 2013;
Thomopoulos et al., 2007). Disorganization of enthesis collagen fibres was also apparent
at 8 weeks of age (Schwartz et al., 2013). Mineralization of the enthesis is also severely
impaired by a loss of mechanical loading, causing an overall reduction in mineral content
as well as altering the characteristics of the mineral crystals (Thomopoulos et al., 2007).
Together these defects ultimately lead to a mechanically inferior tissue that failed under
lower loads (Schwartz et al., 2013).

1.5.4 Tissue Injury and Healing
Tearing in tendons and ligaments is a common orthopedic injury, however, when
the damage sustained involves entheseal tissue significant morbidity can occur. The
muscles involved in the movement of the shoulder are collectively termed the rotator cuff
and tears in these structures due to work and sports related injuries and aging are
common (Ricchetti et al., 2012; Rothrauff and Tuan, 2014). Between 30,000 and 75,000
rotator cuff repairs are performed annually in the United States (relevant Canadian
statistics could not be identified) however the outcome of these surgeries remains poor
(Ricchetti et al., 2012). Post-surgical repair failure rates for minor tears are as high as
20% while the re-tear rate for massive rotator cuff tears are reported to reach a staggering
94% (Derwin et al., 2012; Galatz et al., 2004). Repair failure is due in large part to a lack
of tendon reintegration back into the bone.
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Various studies using animal models have demonstrated that reattachment of a
torn tendon/ligament to bone does not result in the regeneration of an enthesis, but rather
the formation of a fibrovascular scar (Aoki et al., 2001; Fujioka et al., 1998; Rodeo et al.,
1993; Thomopoulos and Williams, 2003). Although these therapies elicited a robust
healing response, the resulting scar tissue did not have the same mechanical integrity as a
true enthesis (Pierre et al., 1995; Thomopoulos and Williams, 2003). A detailed study
using a rat rotator cuff injury model by Thomopoulos and Williams showed that a sharp
boundary forms between the hard and soft tissues, and the continuous collagen fibers
spanning the length of the native enthesis were absent and replaced by a disorganized
matrix rich in type III collagen. Also absent was the gradation of mineral between soft
tissue and bone, thought to be so crucial to stress dissipation. The authors report a tenfold
reduction in the mechanical properties of this tissue (Thomopoulos and Williams, 2003).
Numerous therapies have been developed to overcome this problem, yet none so
far have succeeded in creating a tissue with the same or greater mechanical properties of
the native fibrocartilaginous enthesis. Further study of the composition and development
of this structure, especially in regards to its mineralized portions, are required to develop
better methods of reattaching tendons and ligaments to bones.
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1.6

Purpose of Thesis
A common joint injury is the avulsion or tear of a tendon or ligament from its

attachment point on the skeleton, the fibrocartilaginous enthesis. These injuries cause
significant morbidity, yet surgical and regenerative techniques fail to restore the full
biomechanical properties of the original tissue. Our knowledge of the enthesis is
incomplete, with the specifics of its composition and development still being elucidated.
The calcified fibrocartilage in particular is poorly characterized. Although the presence
and distribution of mineral in the CFC is vital to the mechanical properties and function
of the tissue, a great void in our knowledge exists with regards to the mechanism of
mineral deposition and the regulation of this process within it. Rationale for studying
bone sialoprotein in the fibrocartilaginous enthesis is abundant. BSP’s presence in
mineralizing tissues and its abilities to bind collagen, nucleate HA formation and interact
with osteogenic cells are applicable and transferrable to the development of the
fibrocartilaginous enthesis. In fact, numerous researchers have already highlighted the
similarities and parallels present in the development of growth plates and
fibrocartilaginous entheses. Furthermore, a significant defect caused by the loss of BSP
has been identified at the site where the periodontal ligament attaches to the root of the
tooth. The purpose of this thesis is to establish the presence of BSP in the
fibrocartilaginous enthesis and to characterize the phenotype of this enthesis in the Bsp-/mouse. It is hoped that a better understanding of the role BSP plays in the mineralization
of this structure will further our understanding of its development and ultimately lead to
more effective therapeutic and biomimetic techniques in the regeneration of the
fibrocartilaginous enthesis.
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CHAPTER TWO

IDENTIFICATION OF BONE SIALOPROTEIN IN ENTHESIS
FIBROCARTILAGE AND CHARACTERIZATION OF THE BSP-/FIBROCARTILAGINOUS ENTHESIS
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2.1

Chapter Summary

Tendons/ligaments insert into bone via a transitional structure, the enthesis, which is
susceptible to injury and difficult to repair. Fibrocartilaginous entheses contain
fibrocartilage in their transitional zone, part of which is mineralized. Mineral associated
proteins within this zone have not been adequately characterized. Members of the Small
Integrin Binding Ligand N-Linked Glycoprotein (SIBLING) family are acidic
phosphoproteins expressed in mineralized tissues. Here we show two SIBLING proteins,
bone sialoprotein (BSP) and osteopontin (OPN), are present in the enthesis. Histological
analysis indicate that the calcified zone of Bsp-/- mice is 28% longer in the quadriceps
tendon enthesis, however no difference is apparent in the supraspinatus tendon enthesis.
In an analysis of mineral content within the calcified zone, microCT and Raman
spectroscopy indicate that more mineral is present at the mineralization front of the
quadriceps tendon enthesis in Bsp-/- mice, resulting in a steeper mineral gradient at the
transition between soft and hard tissue. Mechanical testing of the patellar tendon indicate
that while the tendons fail under similar loads, the Bsp-/- patellar tendon is 7.5% larger in
cross sectional area than wild type tendons, resulting in a 16.5% reduction in mechanical
strength. However, picrosirius red staining shows no difference in collagen organization.
Data collected here indicate that BSP and OPN are present in the calcified fibrocartilage
of murine entheses and suggest that BSP plays a regulatory role at the mineralization
front in this structure. BSP appears to be involved in modulating the deposition of
mineral at the mineralization front, ultimately controlling the extent to which the tissue
grows and due to this, loss of BSP may cause a weakening of the tendon mechanical
properties. BSP’s ability to modulate mineral deposition at the enthesis may ultimately
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prove it to be a useful therapeutic molecule in the reattachment of tendons and ligaments
to bone.
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2.2

Introduction
Members of the Small Integrin Binding Ligand N-linked Glycoprotein

(SIBLING) protein family are associated with the mineralized tissues of the skeleton and
dentition (Fisher and Fedarko, 2003). SIBLINGs are anionic phosphoproteins with a
flexible structure and extensive post-translational modifications. The family consists of 5
members: bone sialoprotein (BSP), osteopontin (OPN), dentin matrix protein 1 (DMP1),
dentin sialophosphoprotein (DSPP) and matrix extracellular phosphoglycoprotein
(MEPE), with the encoding genes located in a syntenic gene locus on murine
chromosome five (Fisher and Fedarko, 2003).
BSP is a heavily glycosylated and phosphorylated protein that is expressed at the
onset of mineralization in hard connective tissues (Goldberg and Hunter, 2012). In cellfree systems, BSP has been demonstrated to be a potent nucleator of hydroxyapatite
(HA), the principal mineral component of bone (Hunter and Goldberg, 1993). Nucleation
and binding to HA by BSP is conferred by poly-glutamic acid sequences found in the
central region of the protein (Hunter and Goldberg, 1993; Tye et al., 2003). BSP also
contains an N-terminal collagen-binding domain and it is proposed that binding of BSP to
collagen promotes HA nucleation (Baht et al., 2008; Tye et al., 2005). Finally, BSP
contains an integrin-binding RGD motif, located towards the C-terminus, which promotes
osteoblast differentiation and matrix mineralization (Gordon et al., 2007).
Mice in which the Bsp gene has been ablated (Bsp-/-) have a variety of skeletal and
dental defects. At 4 months of age, these mice display reduced long bone length and
cortical thickness, and a lower rate of bone formation, but have higher trabecular bone
density than wild type mice (Malaval et al., 2008). However, due to an incisor
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malocclusion phenotype on hard diet, some of these defects are ameliorated if Bsp-/- mice
are fed a soft food diet (Soenjaya et al., 2015). Further studies by the Malaval group
showed that the Bsp-/- mouse displays a delay of bone repair in cortical injury models
(Monfoulet et al., 2010) and impaired bone formation and resorption in marrow ablation
models (Wade-Gueye et al., 2012).
More recently, a significant periodontal phenotype has been uncovered in the
Bsp-/- mouse. Acellular cementum is a thin mineralized tissue found along the apical
portion of the root of the tooth, into which the periodontal ligament (PDL) inserts.
Immunohistochemistry shows that acellular cementum is rich in BSP, however in the
Bsp-/- mouse there is a striking reduction in the amount of this tissue (Foster et al., 2013).
Additionally, the Bsp-/- mouse PDL is disorganized, with poorly aligned collagen fibers
that do not properly insert into the tooth root (Foster et al., 2015, 2013; Soenjaya et al.,
2015). However, insertion of the PDL collagen into alveolar bone appears normal (Foster
et al., 2015).
The defects observed in the PDL of the Bsp-/- mouse have spurred us to investigate
other junctions between soft and mineralized tissue. Of particular interest is the enthesis,
the transition site of tendon and ligament insertion into bone. Fibrocartilaginous entheses
are found where tendons or ligaments attach to the epiphysis or apophysis of long bones
(Benjamin and McGonagle, 2001). As such, they are present at several key sites involved
in locomotion, such as where the supraspinatus tendon (SST) of the rotator cuff meets the
epiphysis of the humerus, and where the quadriceps femoris tendon (QCT) inserts into
the back of the patella.
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Fibrocartilaginous entheses contain a fibrocartilage zone containing type II
collagen and fibrochondrocytes at the interface between tendon and bone. As such,
fibrocartilaginous entheses display 4 transitional zones: the dense connective tissue of the
tendon, uncalcified fibrocartilage (UFC), calcified fibrocartilage (CFC), and bone. A
sharp boundary occurs between the calcified and uncalcified fibrocartilage which is
known as the tidemark. Entheses are largely avascular and as such have a limited
potential for regeneration (Benjamin and McGonagle, 2001; Benjamin et al., 2002). Once
torn away from bone, reattachment of a tendon or ligament is difficult. Indeed, the failure
rates for repairs of massive rotator cuff tears remain high despite advances in surgical
technique (Galatz et al., 2004).
Given its HA nucleating and collagen binding properties, and the phenotype
observed in the Bsp-/- mouse PDL, we hypothesize that BSP is present in
fibrocartilaginous entheses and is involved in directing the mineralization and
organization of these structures. In this study we show for the first time that the
mineralized zones of murine fibrocartilaginous entheses contain the SIBLING proteins
BSP and OPN, and that the loss of BSP results in structural, mineral and mechanical
alterations in these entheses and attached tendons.
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2.3.

Materials and Methods

2.3.1 Animals
Animal care followed guidelines of the Canadian Council on Animal Care and
Veterinary Services at the University of Western Ontario. Preparation and genotyping of
Bsp-/- and wild-type mice, maintained on a mixed 129/CD1 background, were performed
as described previously (Malaval et al., 2008). Opn-/- mice were obtained from Jackson
Laboratory (JAX Stock number 004936, Sacramento, USA) and handled as described
previously (Holm et al., 2014). All mice used in this study were fed a soft diet as outlined
by Soenjaya et al. (Soenjaya et al., 2015). Animals used in this study were sacrificed by
CO2 asphyxiation. All comparisons between genotypes were performed on male mice
born in the same litter.
2.3.2 Histology and Immunohistochemistry
Wild type and Bsp-/- shoulder and knee joints from 15 week old mice were
harvested and prepared for histology as described previously with alterations (Wang et
al., 2007) . Briefly, tissue was fixed in neutral buffered formalin (10%) overnight at 4°C
and were then decalcified in 0.65 M EDTA pH 7.4 at 37 °C for three weeks. Tissues were
processed by University Hospital Pathology Core, London, ON, Canada, then embedded
in paraffin and sectioned into 5 µm sections.
Immunohistochemical analysis used in this study is as described previously
(Foster et al., 2013; Holm et al., 2015). Briefly, following standard histological
deparaffinization and rehydration, samples were treated with 3% hydrogen peroxide in
methanol. Heat mediated antigen retrieval was performed in 0.1 M sodium citrate, pH
6.0. Non-specific interactions were blocked using 5% goat serum in PBS for 1 hour at
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room temperature. Sections were then treated with rabbit anti-mouse BSP serum
(courtesy of Dr. Renny Franceschi, University of Michigan School of Dentistry, Ann
Arbor, MI) or rabbit anti-mouse OPN serum (Courtesy of Dr. Larry Fisher, Bethesda,
MD) overnight at 4˚C. Antibodies used in the study have been described previously
(Foster et al., 2013; Ogbureke and Fisher, 2004). 1:200 dilutions in phosphate buffered
saline with 5% goat serum were used for both the OPN and BSP antibodies. In the
morning, sections were washed in PBS-T (0.1% Tween 20, Sigma-Aldrich) then treated
with horseradish peroxidase-conjugated goat anti-rabbit IgG for 1 hour at room
temperature. Sections were again washed with PBS-T, then treated with hydrogen
peroxide and 3,3’-diaminobenzidine (DAB) (Vector Labs). Following DAB
development, sections were counterstained with methyl green, dehydrated, cleared then
mounted in xylene-based mounting medium.
A basic hematoxylin and eosin staining technique was used for this study.
Sections were stained for 10 seconds in Harris’s Hematoxylin (Sigma-Aldrich), then
washed in running tap water for 10 min. Sections were then rinsed briefly in deionized
water and stained with Eosin Y (Sigma-Aldrich) for 1 min. After another rinse in
deionized water, sections were dehydrated and cleared, and then mounted in xylenebased mounting medium.
Von Kossa staining was performed as follows. Tissues were incubated in 2%
silver nitrate for 48 hours. After the silver nitrate solution had permeated the tissues in
their entirety silver ions were precipitated by reduction with sodium hypophosphite (0.6
M) over the course of three days. By this method, elemental silver is deposited as a black
precipitate in areas where hydroxyapatite is present. Tissues were then decalcified in 10%
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formic acid over the course of 10 hours, followed by histological processing and
sectioning as described above. After sectioning, tissues were incubated with 5% sodium
thiosulfate to remove excess nonspecific staining. Sections were counterstained in alcian
blue for 30 min, washed with deionized water, and then stained with nuclear fast red for
10 min. Sections were then dehydrated and cleared followed by mounting in xylenebased mounting medium.
Picrosirius red staining was performed as follows. Tissues were stained with
Sirius red (Sigma-Aldrich) in saturated picric acid for 1 hour. Following staining,
sections were washed in two changes of acidified water, then dehydrated and cleared.
Specimens were imaged using circularly polarized light and collagen organization was
characterized using the methods outlined by Rich and Whittaker (Rich and Whittaker,
2005).
All solutions used in these protocols were made with Milli-Q deionized water
unless otherwise indicated.

2.3.3 Measurement of the calcified fibrocartilage zone
The distance between the tidemark and bone of the SST and QCT entheses were
measured across three transverses drawn parallel to the orientation of the collagen fibres,
by two blinded individuals, in five 15 week-old male wild type and Bsp-/- litter mate
pairs. The lengths of the triplicate measurements in each enthesis were averaged and
these averages were compared between wild type and Bsp-/- mice using a parametric
unpaired t-test.
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2.3.4 Mechanical testing
Immediately after euthanization, the hind limbs of 15 week old mice were
removed and wrapped in PBS soaked gauze, then stored at -20°C prior to mechanical
testing at the University of Pennsylvania. After thawing, the skin of the contralateral
limbs was removed and the patella-patellar ligament-tibia complexes were carefully
dissected under magnification, as described previously (Dunkman et al., 2013). The
tendon cross-sectional area was measured using a custom laser-based device. The anterior
surface of each tendon was speckle-coated with Verhoeff's stain to facilitate optical strain
measurement. Prior to mechanical testing, the tibia was potted in polymethyl
methacrylate (PMMA) and the patella was gripped with a custom aluminum fixtures. The
specimens were then loaded into a materials testing system (Instron, Model 5848;
Norwood, MA, USA) with a 10 N load cell. Throughout the testing, the system was
submerged in a PBS bath maintained at 37°C. All specimens were tested using a
modified version of the protocol outlined in (Dunkman et al., 2013). Briefly, the protocol
consisted of preloading and preconditioning followed by 300 second hold and stress
relaxation at 5% strain After a return to gauge length, a ramp to failure at 0.1%/s was
performed to measure the failure load of the specimens. For data analysis, modulus was
calculated using optical tracking software for each tendon at three regions: (1) the patellar
origin (1 mm distal to the patella), (2) tendon mid-substance and (3) tibial insertion (1
mm proximal to tibial insertion).
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2.3.5 Microcomputed Tomography
Microcomputed tomography (microCT) analysis of the patella was performed
using the eXplore Locus SP scanner (GE Healthcare, London, ON, Canada). 2D images
were acquired using an X-ray tube with a voltage of 80 kVP and a current of 80 mA, with
a 0.508 mm Al filter. The exposure interval time of the scanner was 1600 msec/frame at 4
frames/view. In total, 900 views were obtained at 0.4 degrees angular increments. The
data were reconstructed at a spatial resolution of 13.5 μm. All reconstructed data were
calibrated with a cortical bone phantom (SB3; Gammex RMI, Milwaukee, WI, USA)
with a hydroxyapatite equivalent of 1,100 mg/cc (White 1978), as well as water and air.
Data were analyzed with MicroView ABA version 2.2 (GE Healthcare).
For patellar analysis, 5 mice per genotype were used. Quantification of mineral
density was performed on 3D cubical volumes of interest (VOIs; 20 isotropic voxel size)
identified at the base area, where attachment of the quadriceps tendon occurred.
For measurement of mineral density distribution along the tendon-to-bone
insertion, three parallel transverse line measurements were obtained and averaged for
each region of interest (ROI). The lines were defined manually along the CFC of the
QCT enthesis.

2.3.6 Raman spectroscopy
Three pairs of male wild type and Bsp-/- littermates aged 15 weeks were
euthanized, and the patellae were carefully dissected out following death. Patellae were
then immersed in O.C.T (Tissuetek) and snap frozen. Sagittal sections (10 μm) of the
patellae were cut in a cryostat using a tungsten carbide blade. Sections were quickly
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fixed, washed and dehydrated using an ethanol gradient, and then stored at -80˚C until
scanning.
The apparatus used for Raman spectroscopy was a LabRAM HR (Horiba-JobinYvon, Kyoto Japan) connected to an inverted optical microscope (IX71, Olympus,
Tokyo, Japan) and interfaced with an atomic force microscope system stage
(NanoWizard II Bioscience, JPK Instruments Inc., Berlin, Germany). The protocols used
are as described by (Schwartz et al. 2012). Peak intensity (height) was measured at 960
cm-1, representing the P-O bonds of hydroxyapatite, and 2940 cm-1, representing the C-H
bonds of collagen and other proteins. After baseline correction, the P-O peak was
normalized to the C-H peak, based on the assumption that the collagen content of the
sample was constant at all points measured. Normalized 960 cm-1 hydroxyapatite P-O
peak intensities were then compared between wild type and Bsp-/- samples. For each
individual QCT enthesis, three separate linear measurements were made per enthesis, as
described in the figure legends, lines of measurement were drawn from tidemark to bone
in the orientation of the collagen fibres of the CFC.

2.3.7 Statistical analyses
Quantitative data are expressed as mean ± standard error. For enthesis length and
mechanical comparisons, statistical analyses between experimental groups were
performed using an unpaired parametric t-test. For microCT and Raman spectroscopy,
differences between wild type and Bsp-/- mice was performed using repeated measures
two way ANOVA. All statistical analysis were performed with Prism version 6.00
(GraphPad Software, La Jolla, CA).
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2.4

Results

2.4.1 BSP and OPN are present in the mineralized tissues of fibrocartilaginous
entheses
Immunohistochemistry was performed to determine whether the SIBLING
proteins BSP and OPN are present in the murine fibrocartilaginous entheses. BSP and
OPN were detected in the calcified fibrocartilage of the QCT and SST entheses as well as
the adjacent bone (Fig. 2.1). The absence of BSP and OPN immunostaining was
confirmed in Bsp-/- and Opn-/- mice, respectively (Fig. 2.1).

2.4.2 Bsp-/- mice exhibit defects in calcified fibrocartilage zone of the enthesis
Von Kossa staining of the QCT and SST enthesis indicate approximately
equivalent mineral content in the CFC of the wild type and Bsp-/- enthesis (Fig.
2.2C,D,G,H). However, the CFC is extended in QCT enthesis of Bsp-/- mice (Fig. 2.2AD). The tidemark-to-bone length in the QCT enthesis measured at 178.8 ±15.5 μm for
wild type and 229.1±17.5 μm for Bsp-/- mice (p<0.05, n=5). Surprisingly, no differences
in the length of the CFC was observed in the SST enthesis of Bsp-/- and wild type mice
(Fig. 2.2E-H).
Due to the alteration in the CFC length of the Bsp-/- QCT enthesis, we analyzed
the degree of mineralization along the length of the QCT enthesis. We initially utilized
microCT in order to analyze the mineral distribution along the CFC of the Bsp-/- QCT
enthesis. MicroCT analysis demonstrated that radiodensity in the region corresponding
to the CFC of the QCT enthesis increased rapidly then plateaued (Fig. 3A,B). No
statistically significant difference was observed in radiodensityof the QCT CFC
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Figure 2.1 SIBLING proteins are present in the calcified fibrocartilage of the SST
and QCT entheses. Immunohistochemistry was performed to detect the presence of BSP
and OPN protein (diaminobenzidine staining, brown) in the quadriceps tendon enthesis
(QCT) and supraspinatus tendon enthesis (SST). BSP and OPN were detected in the
calcified fibrocartilage of these entheses and are not present beyond a sharp boundary
representing the tidemark between the CFC and UFC. Negative controls for BSP and
OPN immunostaining of the SST and QCT entheses were performed on Bsp-/- and Opn-/mice respectively. No nonspecific staining in the CFC on control mice was detected.
Wild type and Bsp-/- animals are 15 week old, male, 129/CD1 mice; Opn-/- animals at 15
week old, male, C57Bl/6 mice. CFC: calcified fibrocartilage, UFC: uncalcified
fibrocartilage, bar = 100 μm
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Figure 2.2 Mineral is deposited in the calcified fibrocartilage of Bsp -/ - mice however
the morphology of the clacified fibrocartilage is altered. (C,D,G,H) Von Kossa
staining of the QCT and SST enthesis indicate approximately equivalent mineral content
in the CFC of the wild type and Bsp-/- enthesis. (A,B,E,F) Staining with haematoxylin
and eosin was used to assess gross morphology. An extenson of the calcifed
fibrocartilage was observed, as measured from tidemark to bone (yellow arrow) in the
QCT enthesis (n=5). CFC: calcified fibrocartilage, UFC: uncalcified fibrocartilage, bar =
100 μm
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between wild type and Bsp-/- mice, suggesting that mineral content in the enthesis is
similar (Fig. 3C,D). A slight increase in radiodensity was observed in the region
immediately after the tidemark of the Bsp-/- QCT enthesis compared to wild type,
suggesting that higher levels of mineral are present in this region in the Bsp-/- mouse,
however the difference was not statistically significant (Fig. 3A and B).
Previously, the mineral gradient that occurs at the tidemark was measured to be
approximately 20 m in length (Schwartz et al., 2012). Of relevance, past studies have
shown that a gradient of mineral is present along the enthesis where it is believed to play
a role in stress dissipation (Genin et al., 2009; Schwartz et al., 2012). Since the resolution
of the microCT analysis was limited to 11.5 m, to obtain more definitive analysis,
Raman spectroscopy, which has a resolution of approximately 0.5-0.75 µm, was used to
determine the gradient of mineral content. We used Raman spectrocopy to analyse the
relative difference in intensity between the P-O bonds (peak at 960 cm-1) of phosphate
ions of HA to the organic C-H bonds (peak at 2940 cm-1) of the organic matter present in
the tissue (mostly collagen), in Bsp-/- and wild type mice (Fig. 4A). Raman analysis
mirrored our microCT findings. Mineral content increases rapidly at the tidemark in both
Bsp-/- and wild type mice then platued, with relatively equal levels of mineral being
present in both sets of animals (Fig. 4B). Similar to microCT analysis, a minor increase in
mineral is present near the tidemark in Bsp-/- mice (Fig. 4C,D) however due to the highly
variable nature of Raman signals, statistical significance was not found (p>0.05).
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Figure 2.3 MicroCT analyses indicates similar levels of mineralization in wild type
and Bsp-/- QCT entheses. (A) Three parallel lines (yellow arrows) per individual were
drawn along the orientation of the collagen fibers inserting into bone to analyze changes
in mineral density across the CFC’ then averaged. Lines span from points before the
tidemark across the QCT enthesis and patellar bone into the marrow space. Position 0.00
indicates where radiodensity crossed a threshold of 800 HU, which was estimated to be
the tidemark. (B) Radiodensity, which is an estimate of mineral content, across the
length of the QCT enthesis was similar between wild type and Bsp-/- mice. Radiodensity
trended towards an increase in the region adjacent to the tidemark in Bsp-/- mice. (C)
MicroCT analysis was also performed to determine the overall radiodensity within a 20
voxel region (isotropic voxel size of 11.5 μm) region of the CFC. However, (D) the
results showed no apparent changes in the overall mineral density of the Bsp-/- CFC zone
compared to wild type. HU: Hounsfield units.
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Figure 2.4 Raman spectroscopy shows that the mineral content in the QCT enthesis
is comparable between wild type and Bsp-/- mice. (A) 960 cm-1 hydroxyapatite peak
intensities and 2940 cm-1 collagen peak intensities were analyzed at the tidemark and 5
μm to either side. 960 cm-1 peaks are normalized to the 2940 cm-1 peak at each position
measured. (B) Overall mineral content across the length of the the QCT enthesis is
similar between Bsp-/- and wild type mice. (C,D) Differences in mineral gradients are
more apparent in comparisons of single transverses from individual wild type and Bsp-/littermate pairs due to high variability in mineral to collagen ratios.
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2.4.3 Mechanical testing suggests a weakened enthesis in Bsp-/- mice
Defects noted in the CFC of the QCT enthesis prompted us to determine whether
the strength of Bsp-/- enthesis is compromised. Mechanical testing performed on the
patellar ligament, which links the patella to the proximal end of the tibia, indicated that
its cross-sectional area was approximately 7.5% larger in Bsp-/- mice than wild type (Fig.
2.5); however, the load required to fail the patellar tendon is similar for both genotypes,
indicating that Bsp-/- mice have a weaker patellar tendon with a 16.5% lower failure stress
compared to wild type (Fig. 2.5). Regardless of genotype, the patellar tendon failed at
different positions along its length, with some failures occurring at the enthesis while
others occurring at the tendon midsubstance and, in some cases, failing at more than one
location. Unexpectedly, the local elastic moduli of Bsp-/- patellar tendon at three different
regions: 1) patellar insertion, 2) midsubstance, and 3) tibial insertion were found to be
similar to wild type (data not shown). In addition, the overall percent relaxation and
stiffness of the Bsp-/- patellar tendon were not affected (data not shown).

2.4.4 Collagen organization is not affected by the loss of BSP
Given the mechanical defect observed, as well as the disorganization seen in the
periodontal ligament (Foster et al., 2013), collagen organization was assessed by
picrosirus red staining. Images of wild type and Bsp-/- SST entheses and QCT entheses
were taken using circularly polarized light (Fig. 2.6A). No striking difference in collagen
organization was observed. Hue values, which are an index of collagen fiber thickness,
were quantified using the protocol outlined by Rich and Whittaker (MacKenna and
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Omens, 1994; Rich and Whittaker, 2005)(Fig. 2.6B). The proportions of pixels with
specific hue values is not significantly shifted in Bsp-/- entheses when compared to
wildtype in either the SST or QCT enthesis.
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Figure 2.5 Bsp-/- mice exhibit alteration in patellar enthesis mechanical properties.
At 15 weeks, Bsp-/- mice (n=11) revealed greater cross-sectional area compared to wild
type. During tensile mechanical test, the Bsp-/- mice (n=10) patellar enthesis failed at a
lower stress compared to wild type (n=12). Values shown represent means ± SEM; *p <
0.05.
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Figure 2.6 Collagen organization is not affected by loss of BSP. (A) SST and QCT
entheses of wild type and Bsp-/- animals were stained using picrosirius red and viewed
under circularly polarized light. Red-orange hues represent densely packed collagen
fibers while greenish hues represent more loosely packed collagen fibers. CFC: calcified
fibrocartilage, UFC: uncalcified fibrocartilage, bar = 100μm (B) Hue values for the SST
were quantified. Each image (n=7 for wild type and Bsp-/-) was resolved into 256 bit
colour. The calcified fibrocartilage was manually selected in each image and the number
of pixels with each hue value was counted and divided by the total number of pixels in
the selected area to determine the proportion of pixels with each hue. Hue proportions
were then averaged. Red hues correspond to values between 240-250, orange 251-254
and 1-3, yellow 4-12, green 13-56. Black pixels are given a value of 0 and white pixels a
value of 255 and were omitted from analysis. Note that hues values of interest span the
high and low end of the spectrum, but are presented here as a single peak.
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2.5

Discussion
BSP is an extracellular matrix protein present in mineralized tissues such as bone

and tooth. Here we demonstrate for the first time that BSP is also present in the CFC
zone of the fibrocartilaginous enthesis. OPN was identified for the first time in this
structure as well. The absence of BSP resulted in a lengthening of the CFC in the QCT
enthesis. Furthermore, the Bsp-/- patellar tendon has an increased cross-sectional area and
lower failure stress, however, the overall collagen organization and mineral content of the
Bsp-/- enthesis appeared to be normal. Our findings suggest that BSP plays a role in the
calcified fibrocartilage of the fibrocartilaginous enthesis.

2.5.1 Role of altered calcified fibrocartilage zone of the Bsp-/- QCT enthesis.
In this study, we have shown that BSP, a protein with demonstrated potency to
promote mineral formation in vitro (Hunter and Goldberg, 1993), is present in the CFC
zone of the enthesis. In the same tissue, we also demonstrated the presence of OPN, a
close relative of BSP with inhibitory activity on HA formation (Hunter et al., 1994). The
extracellular matrix composition of fibrocartilaginous entheses has been investigated
previously (Gao et al., 1996; Waggett et al., 1998), however these studies primarily
focused on the various collagens and proteoglycans. The distribution of mineral and
orientation of the collagen fibers in the enthesis has been shown to influence its
mechanical properties (Genin et al., 2009; Liu et al., 2012, 2011; Thomopoulos and
Williams, 2003; Thomopoulos et al., 2005). However, there has been limited attempt to
identify the mechanism by which the CFC is mineralized. To our knowledge, the
presence of mineral associated proteins has never been reported in the enthesis, although
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recently asporin mRNA was identified in the enthesis fibrocartilage of 14-day-old mice
(Liu et al., 2013).
Our previous studies have shown that Bsp-/- mice lack acellular cementum, which
led to PDL detachment and disorganization, and associated periodontal tissue breakdown
such as resorption of alveolar bone and tooth surface (Foster et al., 2013). Minimizing the
mechanical load during mastication, by changing to a soft diet, was not successful in
ameliorating the rate of periodontal breakdown. In spite of this, reducing the mechanical
load has significantly reduced the rate of incisor malocclusion, which affects the Bsp-/mice ability to feed normally. By 8 weeks, long bone lengths normalize when Bsp-/- mice
are fed a soft diet as does overall weight and serum alkaline phosphatase activity
(Soenjaya et al., 2015). Based on the disorganization and detachment in the PDL, we
initially hypothesized that the loss of BSP would have a negative effect on the collagen
structure of the enthesis. However, no changes in the organization of collagen structure in
the CFC of Bsp-/- mouse enthesis was observed. This observation suggests that BSP does
not have a role in collagen organization.
In the absence of BSP, the calcified fibrocartilage of the enthesis still forms and
becomes mineralized. Thus, it is likely that other factors are compensating for the lack of
BSP. Of relevance, our own studies have shown that in contrast to the poor PDL insertion
into acellular cementum, insertion into the alveolar bone was not affected by the absence
of BSP (Foster et al., 2015). It is of interest that at 15 weeks, the Bsp-/- QCT enthesis is
greater in length (28% increase over wild type) compared to wild type at 15 weeks of
age. In contrast, microCT and Raman spectroscopy analysis revealed that there is little
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difference in the level of mineralization within the CFC between Bsp-/- and wild type
mice.
These results indicate mineral deposition and CFC growth are dysregulated in
BSP’s absence. Recently it was shown that active mineralization occurs in a narrow band
of Indian hedgehog (IHH) producing cells at the tidemark and that there is little turnover
in enthesis fibrocartilage once formed (Dyment et al., 2015). Thus is seems likely that
BSP is active at the tidemark. Interestingly, although BSP is thought to be a promineralization factor, the mineralized tissue in the Bsp-/- enthesis is larger in size. It is
possible that in BSP’s absence another pro-mineralization factor is compensating for BSP
and driving excess mineralization in the CFC. Another possibility is that BSP is involved
in cell proliferation through its integrin-binding RGD motif and acts as a regulatory
molecule on enthesis fibrochondrocytes.
Extensions of the mineralized zones of entheses have been documented in other
studies. Polisson et al. have reported lengthening of the mineralized tissues of tendon and
ligament insertions in humans suffering from X-linked hypophosphatemic osteomalacia
(Polisson et al., 1985). Utilizing a murine model of this disorder in which PHEX, a gene
involved in phosphate regulation, has been inactivated, Liang et al. have shown
lengthening of the CFC in the QCT enthesis as well as in the Achilles tendon insertion
into the calcaneus and the attachment of the patellar ligament to the tibial tubercle (Liang
et al., 2009). Interestingly, a related disorder, autosomal recessive hypophosphatemia, is
caused by a loss of function mutation in DMP1 (Lorenz-Depiereux et al., 2006), which is
a close relative of BSP and part of the SIBLING protein family (Fisher and Fedarko
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2003). Characterization of the Dmp1-/- fibrocartilaginous enthesis, however, has not yet
been described.

2.5.2 Bsp-/- patellar tendon exhibit weakened mechanical properties under load.
Interestingly, the Bsp-/- patellar tendon cross-sectional area is greater than the wild
type; however, under mechanical testing, the Bsp-/- patellar tendon failed at a similar
applied load compared to wild type. This implies that the Bsp-/- patellar tendon is weaker
since it requires lower stress, which is a function of both load and cross-sectional area, to
fail. It is possible that a larger patellar tendon cross-sectional area observed in the Bsp-/mouse is a compensatory mechanism which ensures that although the tendon is weaker, it
can withstand the same loads. Similarly, Gao and Messer have hypothesized that the size
of the CFC in an enthesis is related to the tensile load under which it is placed during its
use (Gao and Messner, 1996). The increased size of the QCT CFC in the Bsp-/- mouse
may also be compensating for a weakened tendon. Challenge experiments in which
greater stress is placed on the Bsp-/- enthesis may provide insight as to how mechanical
factors impact BSP’s role in enthesis mineralization.
Furthermore, challenge experiments may reveal a more profound defect caused by
the loss of BSP due to compromised repair processes in the enthesis. BSP has been
implicated in the repair of several mineralized tissues. When BSP and collagen (prepared
by crosslinking BSP to collagen, personal communication E. Salih) are implanted into
calvarial defects of 7-8 week old rats, new bone formation is observed (Wang et al.,
2006). Cortical defects drilled into the femurs of Bsp -/- mice heal slowly when compared
to wild type counterparts (Malaval et al., 2009; Monfoulet et al., 2010). Indeed, given
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BSP’s collagen binding domain, hydroxyapatite nucleating properties and cell attachment
and migration functions, BSP may be an attractive molecule to promote remineralization
in common entheseal injuries such as rotator cuff tears, however further characterization
of BSP’s role in enthesis development is required.
Interestingly, there are many similarities between the development of
fibrocartilaginous entheses and growth plates involved in endochondral ossification
(Zelzer et al., 2014). We and others have recently identified abnormalities in the growth
plates of Bsp -/- mice as well as a delay in mineral deposition during endochondral
ossification (Bouleftour et al., 2014; Holm et al., 2015). By 8 weeks however, Bsp -/- mice
display a normal bone phenotype when fed a soft food diet (Soenjaya et al.¸ 2015). This
suggests that a more pronounced phenotype may be present during the development of
Bsp -/- fibrocartilaginous entheses.
In combination, these data suggest that BSP may play a role in the mineralization
of the CFC of the enthesis. Specifically, BSP seems to be acting at the mineralization
front, the tidemark, of the fibrocartilaginous enthesis where it controls mineral deposition
within a larger regulatory network. In BSP’s absence, other pro-mineralization factors
appear to be compensating, resulting in excess mineralization at the tidemark and a
dysregulation of CFC growth. These defects may ultimately contribute to the weakening
of patellar tendon observed in the Bsp-/- mouse.
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CHAPTER THREE

ELUCIDATING THE ROLE OF BONE SIALOPROTEIN IN THE
MURINE ENTHESIS DURING DEVELOPMENT AND AGEING
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3.1

Chapter Summary
Tendons and ligaments insert into bone through a transitional structure termed the

enthesis which features a region of fibrocartilage, part of which is mineralized. The
mechanism by which this tissue becomes mineralized, however, is poorly characterized.
Recently, bone sialoprotein (BSP), an acidic phosphoprotein associated with mineralizing
tissues, was identified in the calcified fibrocartilage (CFC) of the enthesis, and loss of
BSP resulted in alterations in this tissue in 15 week-old mice. The calcified fibrocartilage
of Bsp-/- mice is 28% longer than wild type in the quadriceps tendon enthesis (QCT)
although overall mineral content within the CFC is similar between genotypes. Bsp-/mice possess defects in endochondral ossification and have abnormal growth plates.
Enthesis development has been suggested to parallel growth plate development in a
number of ways. As such, characterization of the Bsp-/- enthesis in juvenile animals is
warranted to elucidate BSP’s role in this tissues development. Presented is a histological
characterization of the supraspinatus tendon (SST) enthesis and the QCT enthesis of wild
type and Bsp-/- mice at ages of 14 days, 21 days and 14 months. BSP and OPN are not
present in either enthesis at 14 days of age. Small amounts of both proteins were detected
by immunohistochemistry in the SST enthesis at 21 days of age. No differences in the
general morphology were observed between Bsp-/- and wild type tissues in the QCT and
SST entheses at either 14 or 21 days of age. Mineral content, as shown by von Kossa
staining, and collagen organization, as assayed by picrosirius red staining, were also
unaffected. At 14 months of age the Bsp-/- QCT CFC is longer than in wild type mice and
the difference between Bsp-/- and wild type is larger than at 15 weeks, however no other
differences were apparent. Data presented here indicate that loss of BSP has little effect
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on the 14 and 21 day old entheses however loss of BSP appears to cause a dysregulation
of CFC growth that continues well into adulthood.
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3.2

Introduction
Tendons and ligaments transition into bone through a specialized tissue termed

the enthesis. Fibrocartilaginous entheses are the most common category of entheses in the
body and are commonly found at the insertions of tendons, which are connected to
muscles involved in locomotion, into the epiphysis of long bones. As such,
fibrocartilaginous entheses are of critical importance in efficient force transduction from
skeletal muscles to the limbs. In order to effectively connect the soft, pliable material that
makes up tendons and ligaments to the rigid structure of bone, fibrocartilaginous entheses
transition through a region of fibrocartilage, part of which is mineralized. Thus
fibrocartilaginous entheses have been classically described as have four zones: the tendon
proper, uncalcified fibrocartilage (UFC), calcified fibrocartilage (CFC), and bone
(Benjamin and McGonagle, 2001).
Bone sialoprotein (BSP) is an acidic phosphoprotein with a flexible structure and
belongs to the Small Intergrin Binding Ligand N-Linked Glycoprotein (SIBLING) family
of proteins (Fisher and Fedarko, 2003; Ganss et al., 1999). BSP has potent hydroxyapatite
nucleating properties (Hunter and Goldberg, 1993), and binding of BSP to collagen is
thought to promote matrix mineralization (Baht et al., 2008). Previously, BSP was
detected in enthesis CFC and defects were identified in the 15 week old Bsp-/- mouse
quadriceps tendon (QCT) enthesis. The calcified fibrocartilage (CFC) of the enthesis was
28% longer in the Bsp-/- mouse, as measured from tidemark to bone. No changes were
evident in the supraspinatus tendon (SST) enthesis. The Bsp-/- patellar tendon is 7.5%
larger in cross-sectional area than the wild type; however, this tendon has a failure stress
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that is 16.5% lower than wild type indicating that while Bsp-/- tendons are larger, they are
also mechanically weaker.
BSP’s expression and localization coincides with the initial formation of a
mineralized matrix in both intramembranous and endochondral ossification (Bianco et al.,
1991), and BSP is expressed by the hypertrophic chondrocytes within the epiphyseal
growth plate (Chen et al., 1992), among other mineralized tissue associated cells.
Interestingly, there are many similarities between the development of fibrocartilaginous
entheses and growth plates involved in endochondral ossification (Zelzer et al., 2014).
We and others have recently identified abnormalities in the growth plates of Bsp -/- mice
as well as a delay in mineral deposition during endochondral ossification (Bouleftour et
al., 2014; Holm et al., 2015). This suggests that a more pronounced phenotype may be
present during the early development of Bsp -/- fibrocartilaginous entheses. Additionally,
the extension in the QCT CFC observed at 15 weeks suggests that enthesis mineralization
continues over a longer time period in the Bsp-/- mouse. An examination of an older time
point beyond 15 weeks of age would provide additional insight into this observation.
Presented is a histological characterization of Bsp -/- enthesis at three additional time
points, 14 days post-natal, 21 days post-natal, representing developmental time points,
and 14 months of age, representing a time point well into adulthood.
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3.3

Materials and Methods

3.3.1 Animals
Mice were prepared and handled as outlined in Section 2.3.1. Mice aged 14
months and 21 days were all males, however animals 14 days of age used in this study
were male and female. It was assumed that effects on estrogen on the mineralized tissues
under study would be negligible at this age because mice do not reach sexual maturity
until roughly 6 weeks of age (Vandenbergh, 1967) and no gender based differences in
entheseal tissue have been described.

3.3.1 Histology and Immunohistochemistry
Histological techniques used in this study are as described in Section 2.3.2 with
alterations. Fourteen month old mouse limbs were decalcified in 0.650M EDTA at 37 °C
for 3 weeks, 21 day old animals were decalcified in the same solution for 2 weeks and 14
day old animals were decalcified over the course of 7 days using this solution.
In order to decrease background staining of the OPN and BSP antibodies at the 14
and 21 day time points, an adaptation of the immunohistochemistry (IHC) protocol
described in Section 2.3.2 was used. Antigen retrieval was not used on 14 and 21 day old
samples. Antigen blocking was performed in 10% goat serum in phosphate buffer saline
overnight at 4°C. In the morning primary antibody treatment with either rabbit antimouse BSP serum (courtesy of Dr. Renny Franceschi, University of Michigan School of
Dentistry, Ann Arbor, MI) or rabbit anti-mouse OPN serum (Courtesy of Larry Fisher,
Bethesda, MD) was performed for 1 hour at room temperature and half the amount of
antiserum was used.
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Von Kossa staining was performed as described in Section 2.3.2, however,
toluidine blue was used as a counterstain in these studies rather than alcian blue and
nuclear fast red.
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3.4

Results
To better characterize the phenotype of the Bsp-/- murine enthesis, tissues from

older mice, 14 months, and two juvenile time points, 14 and 21 days, were examined via
histology.

3.4.1 Age 14 months
At age 14 months BSP and OPN can still be readily detected in the CFC of the
QCT and SST enthesis and no differences in the distribution of OPN was observed in the
Bsp-/- enthesis (Fig. 3.1 and 3.2). As previously shown, at age 15 weeks a 28% increase in
the length of the QCT enthesis CFC was observed, measured tidemark to bone, in the
Bsp-/- enthesis, while no differences were apparent in the morphology of the SST
enthesis. At age 14 months, the QCT enthesis is further lengthened in the Bsp-/- mouse,
while the size of the wild type CFC in the QCT enthesis did not change between 15
weeks and 14 months of age (Table 3.1). The 14 month wild type CFC of the QCT
enthesis displays an average increase of 30.2 µm from the 15 week Bsp-/- QCT enthesis
and a 41% increase in size over wild type (p<0.05, n=3)(Fig. 3.3). No changes were
noted in the size of the SST CFC of Bsp-/- mice, aged 14 month. Collagen organization, as
demonstrated by picrosirius red staining, remains unaffected by the loss of Bsp (Fig. 3.4).
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Figure 3.1 BSP is present in the calcified fibrocartilage of 14 month-old mice.
Immunohistochemistry using anti-BSP antiserum was performed on the QCT and SST
enthesis of 14 month old male wild type and Bsp-/- mice (n=3). Diaminobenzidine
staining (brown) indicates the presence of BSP protein. CFC: calcified fibrocartilage,
UFC: uncalcified fibrocartilage, bar = 100 μm
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Figure 3.2 OPN is present in the calcified fibrocartilage of 14 month-old mice.
Immunohistochemistry using anti-OPN antiserum was performed on the QCT and SST
enthesis of 14 month old male wild type and Bsp-/- mice (n=3). Diaminobenzidine
staining (brown) indicates the presence of OPN protein. CFC: calcified fibrocartilage,
UFC: uncalcified fibrocartilage, bar = 100 μm
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Figure 3.3 Calcified fibrocartilage of Bsp-/- is further lengthened with age.
Hematoxylin and eosin staining of the QCT enthesis of male 14 month old wild type and
Bsp-/- mice. CFC length (yellow arrow) is increased in the Bsp-/- mouse QCT enthesis
compared to wild type (Table 3.1). CFC: calcified fibrocartilage, UFC: uncalcified
fibrocartilage, T: tidemark, bar = 100 μm
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Table 1. CFC lengths of 15 week and 14 month old wild type and Bsp-/- QCT
entheses. CFC length was measured by drawing three transverses from tidemark to bone
in the orientation of the collagen fibers per individual mouse by two blinded observers
and averaged. Average CFC lengths from wild type and Bsp-/- mice were compared
against each other using a two-tailed, unpaired, parametric t-test. Statistical analysis
indicated significant differences (p<0.05) between genotypes within age groups.
CFC Length (µm)

Wild type

Bsp-/-

15 weeks (n=5)

178.8±15.5 µm

229.1±17.5 µm

14 months (n=3)

182.9±23.7 µm

259.3±17.5 µm
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Figure 3.4 At 14 months of age no differences in collagen organization are observed
between wild type and Bsp-/- mice. Picrosirius red staining of the QCT and SST enthesis
of 14 month old male wild type and Bsp-/- mice (n=3). Collagen fibres (bright objects) are
well ordered in both wild type and Bsp-/- entheses. CFC: calcified fibrocartilage, UFC:
uncalcified fibrocartilage, bar = 100 μm
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3.4.2 Age 14 and 21 days
General morphology of the QCT and SST enthesis of 14 and 21 day old wild type
and Bsp-/- mice was assessed via hematoxylin and eosin (H&E) staining (Fig. 3.5 and 3.6).
No gross morphological differences are apparent between wild type and Bsp-/- entheses.
No tidemark is present in the H&E stains of these time points. At 14 days post-natal the
cartilaginous anlage of the patella is just beginning to mineralize, and while the
attachment point of the quadriceps tendon can be identified, von Kossa staining indicates
that this region of the patella has not mineralized yet (Fig. 3.7). Mineral has reached the
edge of the SST enthesis at 14 days of age but has not yet extended into the developing
fibrocartilage (Fig. 3.7). At 21 days post-natal lamellar bone is beginning to form in the
patella with some individual mice displaying more than others. A small band of mineral
is present in the SST enthesis fibrocartilage (Fig. 3.8). Picrosirius red staining indicates
that collagen content and organization is normal (Fig. 3.9 and 3.10). IHC using antibodies
against OPN and BSP was performed on the murine SST and QCT enthesis at 14 and 21
days post-natal (Fig. 3.11-3.14). BSP and OPN are restricted to the mineralized tissues at
these time points and a thin band of BSP (weakly stained) and OPN can be seen adjacent
to the bone in the SST enthesis, representing the developing mineralization front. Neither
SIBLING proteins are present in the developing QCT enthesis at these time points.
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Figure 3.5 No gross morphological differences are apparent in the entheses of 14
day-old wild type and Bsp-/- mice. General morphology of the QCT and SST enthesis of
14 day old male and female wild type and Bsp-/- mice was assessed by standard
hematoxylin and eosin staining (n=5). Bar = 100 μm
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Figure 3.6 No gross morphological differences are apparent in the entheses of 21
day-old wild type and Bsp-/- mice. General morphology of the QCT and SST enthesis of
21 day old male wild type and Bsp-/- mice was assessed by standard hematoxylin and
eosin staining (n=5). Bar = 100 μm
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Figure 3.7 Mineral is not present in the entheses of 14 day-old wild type and Bsp-/mice. Whole tissue von Kossa staining was performed on the QCT and SST entheses of
14 day old male and female wild type and Bsp-/- mice (n=5). Mineral deposition is
represented in black. Sections are counterstained with toluidine blue. Bar = 100 μm
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Figure 3.8 Mineral is not present in the QCT enthesis of 21 day-old wild type and
Bsp-/- mice however small amounts are present in the SST enthesis. Whole tissue von
Kossa staining was performed on the QCT and SST entheses of 21 day old male wild
type and Bsp-/- mice (n=5). Yellow circle demarcates the enthesis. Mineral deposition is
represented in black. Yellow arrows indicate early sites of mineral deposition in the
enthesis. Sections are counterstained with toluidine blue. Bar = 100 μm
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Figure 3.9 At 14 days of age no differences in collagen organization are observed
between wild type and Bsp-/- mice. Picrosirius red staining of the QCT and SST
enthesis of 14 day old male and female wild type and Bsp-/- mice (n=5). No apparent
differences in the organization of collagen fibers (bright red/green) are present in wild
type and Bsp-/- entheses. Bar = 100 μm
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Figure 3.10 At 21 days of age no differences in collagen organization are observed
between wild type and Bsp-/- mice. Picrosirius red staining of the QCT and SST enthesis
of 21 day old male wild type and Bsp-/- mice (n=5). No apparent differences in the
organization of collagen fibers (bright red/green) are present between wild type and Bsp-/entheses. Bar = 100 μm
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Figure 3.11 BSP is not present in the entheses of 14 day old wild type and Bsp-/- mice.
Immunohistochemistry using anti-BSP antiserum was performed on the QCT and SST
enthesis of 14 day old male and female wild type and Bsp-/- mice (n=5).
Diaminobenzidine staining (brown) indicates the presence of BSP protein. Bar = 100 μm
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Figure 3.12 BSP is localized to mineralized regions in 21 day old wild type mice.
Immunohistochemistry using anti-BSP antiserum was performed on the QCT and SST
enthesis of 21 day old male wild type and Bsp-/- mice (n=5). Diaminobenzidine staining
(brown) indicates the presence of BSP protein. Bar = 100 μm
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Figure 3.13 OPN is not present in the entheses of 14 day old wild type and Bsp-/mice. Immunohistochemistry using anti-OPN antiserum was performed on the QCT and
SST enthesis of 14 day old male and female wild type, Bsp-/- and Opn-/- mice (n=5).
Diaminobenzidine staining (brown) indicates the presence of OPN protein. Bar = 100 μm
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Figure 3.14 OPN is localized to mineralized regions in 21 day old wild type and Bsp/- mice.

Immunohistochemistry using anti-OPN antiserum was performed on the QCT

and SST enthesis of 21 day old male wild type, Bsp-/- and Opn-/- mice (n=5).
Diaminobenzidine staining (brown) indicates the presence of OPN protein. Bar = 100 μm
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3.5

Discussion
In order to further elucidate the role of BSP in the fibrocartilaginous enthesis, a

histological characterization of the BSP null enthesis was performed in mice of 14 days,
21 days and 14 months of age. At 14 days BSP and OPN protein are not present in the
QCT and SST entheses in wild type animal. At 21 days small amounts of BSP and OPN
appear to be present near the bone in the SST enthesis, while no positive staining is
observed in the QCT enthesis. Little change was observed in the general morphology,
mineral deposition, collagen organization and OPN protein localization of Bsp-/- mice. At
14 months of age immunohistochemical staining indicates no differences in the staining
patterns of BSP and OPN from that observed at 15 weeks of age, and collagen
organization remains unaffected by loss of BSP at age 14 months. Interestingly, the CFC
of the QCT enthesis is further lengthened beyond measurements from 15 weeks of age,
suggesting a dysregulation in the growth of this tissue in the absence of BSP.

3.5.1

14 months
In captivity, mice live to two to three years of age. At the age of 14 month the

only notable abnormality in the Bsp-/- mouse enthesis is the extension of the CFC
observed in the QCT enthesis. As previously noted this phenotype was first observed at
15 weeks of age, however the increase in CFC length is larger at 14 months of age. Wild
type CFC length remains the same from 15 weeks to 14 months of age, suggesting that
this tissue is fully mature by 15 weeks with outward growth of the mineralization front
ceasing at some point prior. The increase in length of the Bsp-/- enthesis suggests that the
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mineralized region continues to expand in the absence of BSP. BSP has traditionally been
described as a promoter of mineralization, for which there is strong in vitro evidence
(Hunter and Goldberg, 1993). However, in this instance BSP appears to be acting as a
regulator of mineral growth, modulating the extent to which the mineralization front in
the CFC extends outwards from the bone.
An analysis of the mineral content at the tidemark in the 14 month old Bsp-/mouse by Raman spectroscopy is warranted, as the mineral gradient at 14 months may be
steeper still. Unfortunately Raman spectroscopy could not be conducted on 14 month old
animals at this time as the animals used in this study were taken from a preserved archive
of mice maintained by our laboratory. While animals kept in this fashion are suitable for
histology, Raman spectroscopy requires fresh tissue, which could not be generated in a
timely manner due to the age of the animals.
Future investigations at this time point should include mechanical studies on the
Bsp-/- QCT as it may provide insight as to the functional significance of the lengthened
CFC. Mathematical and mechanical modelling suggest that alterations in the length of the
CFC in the magnitudes observed at this time point may result in weakening of the
tendon-bone insertion due to the enlarged regions of presumably stiffer tissue, and if
further abnormalities are present in the gradient region it may exacerbate the tendon
defect further (Genin et al., 2009).
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3.5.2

14 and 21 days
Due to BSP’s role in mineralizing tissues, the apparent similarities in growth plate

development and enthesis development, and the deficiencies identified in endochondral
ossification in the Bsp-/- mouse, it was hypothesized that BSP may play a role in enthesis
development and mineralization. Furthermore, it was hoped that phenotypes caused by a
loss of BSP would be more apparent during development. Entheses develop post-natally
(Zelzer et al., 2014), and a mineral gradient is apparent in the SST enthesis as early as 14
days postnatal (Schwartz et al., 2012). By 21 days the developing SST enthesis begins to
resemble the morphology of the mature enthesis when examined histologically (Schwartz
et al., 2012). Based on this knowledge, time points of 14 and 21 days of age were chosen
for study. No developmental characterization of the mineral content of the developing
murine QCT enthesis has been described.
In the fibrocartilaginous enthesis, BSP and OPN appear to be restricted to sites of
mineralization. BSP and OPN’s absence in the extracellular matrix (ECM) of the 14 day
old SST and QCT entheses is not surprising as these structures are not mineralized at this
time point. Due to the lack of BSP in wild type tissues at 14 days of age, it is to be
expected that the Bsp-/- mouse does not display an enthesis phenotype when examined
histologically at this time point. At 21 days post-natal, mineral is just beginning to be
deposited in the developing enthesis fibrocartilage in the SST, however no differences are
apparent in general morphology, mineral deposition or collagen organization between
wild type and Bsp-/- mice, consistent with our observations in mice 15 weeks and 14
months of age. The mineralization front in the patella has not yet expanded into the QCT
enthesis fibrocartilage by 21 days of age, and as such, neither BSP nor OPN are present
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in wild type tissue. Unsurprisingly, no differences are apparent in 21 day old Bsp-/- QCT
morphology.
Further characterization of the developing Bsp-/- enthesis is needed to elucidate
BSP’s role in enthesis development. A histological characterization at 28 days post-natal
is suggested, since at this time point mineral deposition in enthesis fibrocartilage is likely
occurring. Further time points moving toward 15 weeks of age could also be assessed in
order to determine at what age the Bsp-/- CFC length begins to outpace wild type tissue.
A major shortcoming in the histological analysis of BSP within enthesis tissue is
the BSP antibody’s unfortunate affinity for cells located in uncalcified fibrocartilage, as
well as muscle tissues. Our original IHC protocol used on 15 week old mice from our
previous study and the 14 month old mice shown here, is effective in demonstrating BSP
staining in the ECM. Intense brown staining is present in the CFC ECM of wild type
animals while no ECM staining is observed in control Bsp-/- entheses. Cells located in the
UFC however stain positive in both wild type and Bsp-/- mice, indicating that the BSP
antiserum possesses some nonspecific binding activity. In the 15 week and 14 month old
mice we were interested in showing that BSP is present in the ECM, and as cellular
nonspecific staining is a common problem in IHC stains, this issue was not addressed at
these time points. In the analysis of the 14 and 21 day old animals, where little mineral is
present and uncalcified regions of fibrocartilage are more abundant, nonspecific cellular
staining was much more evident. At these time points we were interested in whether BSP
protein could be detected in the ECM and the cells of the developing enthesis, which
would eventually become the CFC, however the non-specific staining prevented us from
adequately addressing this question. A new protocol was developed for both BSP and
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OPN antisera, which was intended to reduce the amount of nonspecific cellular staining.
The altered protocol was effective in reducing nonspecific staining in OPN antiserum,
however this protocol was less effective for the BSP antiserum, since it drastically
reduced the staining intensity of both specific staining in bone and nonspecific cellular
staining. Indeed, the BSP research field in general lacks an effective anti-BSP antibody.
While numerous biotech companies claim to provide anti-BSP antibodies, none so far
have produced an antibody that adequately meets the demands of all of the researchers in
the field.
To conclude, these studies have shown that loss of BSP results in an increased
lengthening of the CFC of the QCT entheses in 14 month old mice beyond what was
observed in 15 week old animals. This observations suggests a defect in the regulation of
CFC growth in the QCT enthesis in the absence of BSP. All other parameters measured
in 14 month old mice remained unaffected by the loss of BSP. During development, BSP
and OPN are not present in 14 day old murine entheses. In 21 day old entheses small
amounts of these proteins may be present in the SST enthesis, but are absent in the QCT
enthesis reflecting the amount of mineral present in entheses studied at these times. This
observation suggests that BSP and OPN are restricted to mineralized sites in the enthesis.
Further characterization at 28 and 42 days post-natal is warranted to uncover BSP’s role
in enthesis development and mineralization.
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GENERAL DISCUSSIONS AND CONCLUSIONS
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4.1

Summary and Perspectives
Fibrocartilaginous entheses are transitional structures that connect tendons and

ligaments to bone and contain a region of fibrocartilage with a mineralized component.
Prior to these studies, mineral-associated proteins present in the calcified fibrocartilage
(CFC) of the enthesis remained essentially uncharacterized and the mechanism by which
mineral is deposited in enthesis fibrocartilage left unidentified. Bone sialoprotein (BSP)
is an extracellular matrix protein commonly found in mineralizing tissues and has potent
hydroxyapatite nucleating, collagen binding and cell signaling properties (Goldberg and
Hunter, 2012). BSP has recently been implicated in the connection of periodontal
ligament to the root of the tooth (Foster et al., 2013). The studies reported in this thesis
have identified the presence of the mineral associated proteins BSP and OPN in the
calcified tissues of the murine fibrocartilaginous enthesis in adult animals. Furthermore,
it was shown that the loss of BSP results in abnormalities in the CFC of the quadriceps
tendon (QCT) enthesis. Specifically, the CFC of the QCT enthesis in adult mice is
elongated, and this elongation increases with age. Mineral content within the CFC was
found to be comparable between Bsp-/- and wild type mice, as demonstrated by Raman
spectroscopy and microCT. Collagen organization in the enthesis was not affected by the
loss of BSP at any time point measured, in contrast to the phenotype observed in the
periodontal ligament (Foster et al., 2013). During development, OPN and BSP are
restricted to the mineralized regions of the enthesis. By 21 days of age, small amounts of
mineral, along with BSP and OPN, can be detected in the fibrocartilage of the developing
supraspinatus tendon (SST) enthesis. However, no phenotype is observed in the entheses
of Bsp-/- mice at this time point, in line with observations in the adult animal. In the QCT
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enthesis, mineral is not yet present in the enthesis fibrocartilage by 21 days post-natal and
as such, BSP and OPN are not present at this time point and no phenotype is observed in
the Bsp-/- mouse.
BSP has long been thought to be a promoter of mineralization, and there is strong
in vitro evidence for its hydroxyapatite nucleating properties (Hunter and Goldberg,
1993). Phenotypes in the Bsp-/- mouse such as delays in early mineralization in the long
bones (Bouleftour et al., 2014; Holm et al., 2015); defects in bone repair after injury
(Malaval et al., 2009); and acellular cementum deficiencies (Foster et al., 2013), are
small, but also point towards BSP being a promoter of mineralization. The phenotype
observed in the Bsp-/- enthesis, however, suggests a different role for BSP in this tissue.
The extension of the QCT CFC indicates that more mineral, not less, is present in the
Bsp-/- fibrocartilaginous enthesis. BSP’s expression at sites where mineralization is
actively occurring has long been established (Bianco et al., 1991), and BSP is particularly
abundant at mineralization fronts in bone (Bianco et al., 1993). Recently it was shown
that active mineralization in the enthesis occurs in a narrow band of Indian hedgehog
(IHH) producing cells at the tidemark and that there is little turnover in enthesis
fibrocartilage once formed (Dyment et al., 2015). Thus is seems likely that BSP is active
at the tidemark. It would appear that at the enthesis mineralization front, BSP is acting as
a regulator of mineralization, controlling mineral deposition at this site to ensure that the
tissue is the appropriate size and the mineral gradient at the tidemark is properly formed.
A delicate balance between pro- and anti-mineralization factors must occur at the
tidemark, and the phenotypes observed in the Bsp-/- fibrocartilaginous enthesis suggest
that BSP is one of possibly a number of factors active at this site. In BSP’s absence, the
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balance is disrupted, with other pro-mineralization factors compensating for BSP, driving
excess mineralization at the tidemark.

4.2

Limitations of Research and Future Directions

4.2.1

Phenotypic differences in different entheses and the role of muscle loading
A curious observation of these studies is that while alterations are present in the

mineralized tissues of the QCT enthesis, there is an apparent lack of a phenotype in the
SST enthesis. It is reasonable to assume that because both are fibrocartilaginous entheses,
loss of BSP would result in the same phenotypic observations in both structures.
However, in fibrocartilaginous entheses there are factors beyond biological and genetic
ones that influence the structure’s development.
The role of mechanical factors in the development of the tissues of the
musculoskeletal system are well established (Galloway et al., 2013; Gkiatas and
Lykissas, 2015), and the role of mechanical cues in the enthesis has been analyzed as
well. In entheses that display a large change in insertional angle during joint movement, a
larger region of uncalcified fibrocartilage (UFC) is observed (Benjamin and McGonagle,
2001; Benjamin and Ralphs, 1998). Since this enthesis zone is more pliable than either
tendon or the CFC, researchers have hypothesized that the increased amount of UFC aids
in smooth movement of the joint during its total range of movement. Gao and Messer
suggest that the size of the CFC is determined by the tensile load that the enthesis is
under at puberty (Gao and Messner, 1996). When the shoulder muscles of newborn mice
are paralyzed with botulinum toxin, decreased mineralization near the SST enthesis in the
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bone was observed at 21 days of age and fibrocartilage failed to form at the insertion
(Thomopoulos et al., 2007).
Since the genetic factors at the QCT and SST entheses in the Bsp-/- mouse are the
same, the anatomical location and function of these entheses must be considered. The
muscles attached to the QCT are some of the largest and most powerful muscles in the
body, in both mice and humans. Located on the anterior surface of the femur, they are
involved in the extension of the leg and are used extensively during locomotion. The
QCT inserts directly into the back of the patella rather than obliquely or by wrapping
around another anatomical feature. As such, the tensile force on the QCT enthesis under
load is large and the insertional angle is small. In contrast, the supraspinatus muscle is
located in the shoulder and its contraction drives the initiation of abduction of the arm at
the shoulder joint. The muscle is smaller than the quadriceps muscles and produces loads
of a lower magnitude. Furthermore the SST makes contact with bone at an oblique angle,
wrapping around the head of the humerus before inserting at the SST enthesis. As such
the nature of the loads in the QCT and SST entheses are quite different, and these
differences may be the cause of the discrepancies in phenotypes observed in the Bsp-/mouse. In order to investigate the interplay between muscle load and BSP’s regulatory
role in enthesis development, paralysis experiments, such as those described above, on
the lower limbs of Bsp-/- mice should be considered.

4.2.2

Establishing the expression of BSP in the enthesis
While these studies have established the presence of BSP and OPN protein in the

enthesis, the question of whether these proteins are expressed in the enthesis remains
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unanswered. Fibrochondrocytes of the enthesis have much in common with the
chondrocytes of the growth plate (Zelzer et al., 2014), and BSP expression in
hypertrophic chondrocytes has been demonstrated via in situ hybridization experiments
(Bianco et al., 1991). It seems reasonable that the fibrochondrocytes of the CFC are the
source of the BSP and OPN identified in the matrix. However, observations in 14 and 21
day old mice indicate that BSP and OPN are restricted to mineralized tissues in the
enthesis, if present, and to bone, with no matrix staining present in the regions of the
enthesis that have not yet become mineralized. BSP and OPN have a high binding
affinity for hydroxyapatite (HA) (Goldberg et al., 2001), and as such, BSP and OPN
could be expressed exogenously and become localized to the CFC by virtue of their
acidic domains rather than being expressed endogenously within the tissue.
In hopes of determining if BSP is expressed by enthesis fibrochondrocytes, real
time quantitative PCR (qPCR) experiments were attempted but were ultimately
unsuccessful. In order to harvest mRNA from enthesis fibrochondrocytes for qPCR
analysis, a laser capture microdissection (LCM) procedure was employed to specifically
isolate fibrochondrocytes from the enthesis and avoid contamination with cells from bone
and/or tendon. The LCM apparatus is a standard optical microscope equipped with a high
power cutting laser and a low power catapult laser. It allows a user to examine a
histological section and select specific regions to excise with the cutting laser. The
excised specimen is then catapulted into a collection tube by the catapult laser for
subsequent analysis.
LCM is traditionally used on soft tissues to isolate specific cell types for qPCR
analysis. Working with a mineralized tissue such as the enthesis present unique
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challenges. Traditional histological analysis of mineralized tissue involves a lengthy
decalcification process. The protocol used by our laboratory immerses tissue in high
molarity EDTA for 3 weeks at 37 ˚C. Due to the unstable nature of RNA molecules,
cryosectioning of fresh tissue prior to LCM is required to acquire sufficient mRNA yields
for qPCR analysis. This necessitated the development of a method to section through
solid patellae quickly to preserve RNA integrity while maintaining the structure of the
tissue, so that the enthesis could be easily identified and excised during LCM. To
overcome this obstacle we utilized a blade made of tungsten carbide, which is much
harder than traditional stainless steel blades, which allowed us to cleanly cut fresh
patellar sections without tearing the tissue. Although this method was ultimately not
useful for obtaining RNA from entheseal tissue, it was critical to facilitate our Raman
spectroscopy studies, which also required fresh, undecalcified tissue sections.
qPCR functions on the premise that the amount of RNA present in a sample is
proportional to the number of PCR cycles the sample must undergo before reaching a
critical threshold (CT) in which the PCR amplification becomes exponential. Data
returned from qPCR analysis on enthesis fibrochondrocytes yielded CT values in the
range of 30-40 PCR cycles, well beyond the range which is considered reliable (generally
25 cycles or lower). This data indicates that very little to no RNA was present in our
qPCR reactions, indicating a poor yield from the LCM extraction protocol. When
considering the nature of the tissue under study and the process used, low RNA yield is
understandable. Fibrocartilage in general is a hypocellular tissue, with each CFC section
taken containing perhaps 40 cells. Several sections per individual were pooled together
for qPCR analysis, however this did not appear to ameliorate the issue. Furthermore,
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tissue used in this study was taken from animals 15 weeks of age. At this age the
fibrochondrocytes of the CFC are mature and are not likely to strongly express matrix
genes, and so BSP and OPN mRNA are likely sparse in these cells to begin with. This
study highlights the many obstacles and difficulties present in conducting gene
expression experiments on the mineralized tissues of the enthesis. Liu et al. did
successfully perform qPCR analysis via LCM on enthesis fibrocartilage, however in this
study tissue was taken from a developing enthesis in juvenile mice (age 14 days) and no
mineralized tissue was present at this time (Liu et al., 2013). In situ hybridization is
another commonly used technique to detect the presence of specific RNA molecules in
tissues and our laboratory is currently pursuing experiments of this nature on enthesis
fibrocartilage to establish BSP and OPN expression there.

4.2.3

Other potential mineralization factors in the enthesis
In line with other mineralized tissues, excluding acellular cementum, loss of BSP

in the enthesis does not cause a gross inability to form calcified tissue in the enthesis.
Biomineralization is a complex and multifactorial process with a great deal of functional
redundancy between the different players that regulate mineralization. Here we have
identified two mineral associated proteins in the enthesis, and partially characterized the
role of one factor involved in the formation of the CFC. In order to have a more complete
understanding of the mechanism and regulatory network that controls formation of
enthesis CFC, additional mineralization factors must be identified.
One potential candidate is dentin matrix protein 1 (DMP1), a fellow member of
the SIBLING family with similar properties to BSP. Originally thought to be specific to

131
dentin, DMP1 has been identified in bone, cartilage and cementum as well (D’souza et
al., 1997; Feng et al., 2003; George et al., 1995; Hirst et al., 1997; Macdougall et al.,
1998). DMP1 possesses an RGD integrin-binding motif (Kulkarni et al., 2000), and has
been reported to bind collagen in the hole zones (He and George, 2004), and promote
mineral deposition. Under some conditions DMP1 can act as a nucleator of HA formation
(He et al., 2003); however, under other conditions it can act as an HA inhibitor
(Silverman and Boskey, 2004). Thus, there is still controversy in the field regarding the
role of DMP1 in mineralization. During the course of the studies outlined in this thesis,
DMP1’s presence in enthesis fibrocartilage was probed as well. Immunohistochemistry
revealed inconsistent results for DMP1 localization, with some entheses strongly staining
for DMP1, while others stained weakly and in some no staining at all was detected. The
presence or absence of staining did not correspond with BSP genotype and surprisingly,
different entheses taken from the same mouse displayed different staining results. Further
investigation is required to elucidate the reasons accounting for DMP1’s erratic staining
pattern in the enthesis.
Another potential mineralization factor in the enthesis is asporin, so named
because it is a member of the small leucine-rich repeat proteoglycan family which
includes decorin and biglycan, and because it possesses a contiguous sequence of
aspartate (Asp) residues in its N-terminal domain (Henry et al., 2001). Asporin binds type
I collagen, which is competitively inhibited by decorin, indicating that the two proteins
occupy the same binding site (Kalamajski et al., 2009). Asporin’s poly D sequence
appears to possess calcium-binding properties (Kalamajski et al., 2009), similar to the
properties conferred to BSP and OPN by their acidic domains (Goldberg et al., 2001). In
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osteoblast cell culture, addition of asporin to culture media results in an increase in
mineral nodule formation and expression of the osteoblastic cell markers osterix and
Runx2, as shown by qPCR (Kalamajski et al., 2009). In a study of smoothen (Smo)
knock-out mice, Liu et al. identified Aspn mRNA in developing enthesis fibrocartilage
using RNAseq and qPCR. In mice in which the Smo gene is ablated (Smo-/-), enthesis
fibrocartilage fails to mineralize and RNAseq and qPCR analysis indicate that there is a
3.9 fold reduction in Aspn expression in Smo-/- enthesis fibrocartilage (Liu et al., 2013).
Clearly asporin plays some role in the mineralization process of enthesis fibrocartilage
however further studies are required, as the presence and localization of asporin protein
in the enthesis has not yet been established.
Ultimately it is hoped that the search for factors and molecules that regulate
mineral deposition and enthesis development will lead to advances in enthesis repair,
specifically in tissue engineering. Numerous cell, growth factor and biomaterial based
implants and grafts have been developed in an attempt to regenerate the complex
transitional zones of the enthesis, however none so far have successfully created a
biocompatible material with the same mechanical properties of the native enthesis (Lu,
2013). Currently, the major hurdle in clinical translation of these therapies is successful
integration of the graft into the existing musculoskeletal system. Given its cell binding
properties and its apparent role in the regulation of the formation of the CFC, BSP may
ultimately prove to be a useful molecule in the reattachment of tendons and ligaments
into bone.
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4.3

Conclusions
These studies have identified the SIBLING proteins BSP and OPN in the CFC of

the murine fibrocartilaginous enthesis, showing for the first time the presence of these
mineral associated proteins in the enthesis. The enthesis phenotype of mice that lack BSP
was examined in order to elucidate the role of BSP in enthesis fibrocartilage. In the
absence of BSP, the growth of the CFC appears to be dysregulated in the QCT enthesis,
which continues to increase in size well into adulthood. In the absence of BSP, the body
may compensates with an increase in the cross-sectional area of tendons in the Bsp-/mouse. Due to the known properties of BSP, it may still be involved at the mineralization
front of the fibrocartilaginous enthesis where it likely contributes to a complex network
of proteins which act to control the growth of the CFC and regulate mineral deposition in
the enthesis. As such, BSP may ultimately prove to be a useful molecule in the
reattachment of tendons and ligaments into bone.
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APPENDIX A
Statement of Permission for the Use of Animals for Experimental Research.
All animal experimentation was performed in compliance with the animal use protocol
2008-092. This protocol is held by Dr. Harvey Goldberg, a principal investigator at the
Schulich School of Medicine and Dentistry and the Department of Biochemistry at the
University of Western Ontario, London, Ontario, Canada.

138
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Statement of Permission for the Use of Published Materials (Figure 1.2)
Dear Mr Marinovich
We hereby grant you permission to reprint the material below at no charge in your thesis, in
print and on the University of Western Ontario web site subject to the following conditions:

1.
If any part of the material to be used (for example, figures) has appeared in our
publication with credit or acknowledgement to another source, permission must also be
sought from that source. If such permission is not obtained then that material may not
be included in your publication/copies.
2.
Suitable acknowledgment to the source must be made, either as a footnote or
in a reference list at the end of your publication, as follows:
“This article was published in Publication title, Vol number, Author(s), Title of article,
Page Nos, Copyright Elsevier (or appropriate Society name) (Year).”
3.

Your thesis may be submitted to your institution in either print or electronic form.

4.
Reproduction of this material is confined to the purpose for which permission is
hereby given.
5.
This permission is granted for non-exclusive world English rights only. For other
languages please reapply separately for each one required. Permission excludes use in
an electronic form other than as specified above. Should you have a specific electronic
project in mind please reapply for permission.
6.
This includes permission for the Library and Archives of Canada to supply single
copies, on demand, of the complete thesis. Should your thesis be published
commercially, please reapply for permission.

Kind regards
__________________________________________________________
Steph Norton :: Rights Associate :: Global Rights :: ELSEVIER
T: +44 (0)1865 843325 :: F: +44 (0)1865 853333
E: s.norton@elsevier.com
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